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The Role of the R-domain in Regulated Trafficking of the Cystic Fibrosis 
Transmembrane Conductance Regulator. 
 
Christopher M. Lewarchik, PhD 
University of Pittsburgh, 2008
 
The cystic fibrosis transmembrane conductance regulator (CFTR) is a phosphorylation-
regulated chloride channel that is a member of the ATP-binding cassette (ABC) 
transporter family [1]. It is involved in the movement of chloride ions across epithelial 
membranes in the airways, sweat glands, intestine and pancreas [2].  Mutations in CFTR 
that result in a loss of channel function result in the disease cystic fibrosis, affecting 
nearly 1 in 2500 people in northern Europe and the United States [3].  As a member of 
the ABC transporter family, CFTR shares the structural features of these proteins.  
Unique to CFTR is the presence of a cytoplasmic R-domain, that contains multiple 
phosphorylation sites.  Phosphorylation of the R domain is required for CFTR channel 
gating, and cAMP/PKA simulation can also elicit insertion of CFTR into the plasma 
membrane from intracellular compartments [4].  We evaluated the structural basis of 
regulated CFTR trafficking by determining agonist-evoked increases in plasma 
membrane capacitance (Cm) of Xenopus oocytes expressing CFTR deletion mutants.  
Expression of CFTR as a split construct that omitted the R-domain (Δaa 635-834) 
produced a channel with elevated basal current (Im) and no ΔIm  or trafficking response 
(ΔCm) upon cAMP/PKA stimulation, indicating that the structure(s) required for 
regulated CFTR trafficking are contained within the R domain.  Additional deletions 
 iv 
showed that removal of amino acids 817-838 produced a channel with regulated gating 
that lacked the agonist-induced increase in CFTR trafficking.  This 22aa region exhibits 
helical structure, bears a net negative charge of -9, is highly conserved among species, 
and has been termed NEG2 [5, 6].  Injection of NEG2 peptide into oocytes expressing 
split ΔNEG2 CFTR prior to stimulation restored the agonist-evoked ΔCm, consistent with 
the concept that this sequence mediates regulated CFTR trafficking.  Further 
modifications of NEG2 suggest that the trafficking phenotype depends primarily on its 
helical structure.  These observations suggest that the NEG2 region at the C-terminus of 
the R domain allows CFTR to enter a regulated intracellular compartment from which it 
traffics to the plasma membrane in response to cAMP/PKA-stimulation. 
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1.0  INTRODUCTION 
1.1 THE CELL MEMBRANE: 
In 1855, Carl Wilhelm von Nägeli and Hugo von Mohl ushered in the science of 
membrane biology.  In their studies, they suggested the presence of a biological 
membrane based on their microscopic observations of plant cells [7].  German 
physiologist Wilhelm Pfeffer refined the definition of biological membranes in 1875 
when he suggested that membranes were discrete structures that could serve as selective 
barriers [8].  “Pfeffer’s Postulate” served to establish the paradigm that cells contained 
some type of membrane structure which functioned to separate the inner cytosolic 
domain from the extracellular luminal environment.   Additional studies by Gorter, & 
Grendel et al., and Danielli & Davson et al., [9, 10] were required to fully develop our 
current view of the plasma membrane as a bilayer composed of two opposing layers of 
lipid molecules arranged so that their hydrocarbon tails face one another to form an oily 
core, while their charged heads face the aqueous solutions on either side of the 
membrane.  
 The previous decades of research have led to several generally accepted 
characteristics of biological membranes.  The first is that biological membranes are made 
up of a mixture of lipids and proteins, an idea that was initially proposed by Davson & 
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Danielli in 1935 [10].  The second generally accepted membrane characteristic is that the 
cell membrane consists of three classes of amphipathic lipids: phospholipids, glycolipids, 
and cholesterol which spontaneously arrange so that the hydrophobic "tail" regions are 
shielded from the surrounding polar fluid, causing the more hydrophilic "head" regions to 
associate with the cytosolic and extracellular faces of the resulting bilayer.    These 
observations culminated in the proposal of the fluid-mosaic model of biological 
membranes by Singer & Nickelson in 1972 [11].   
 
 
Figure 1-1: Fluid Mosaic Model of Plasma Membrane [11]. 
This model proposes that the biological membrane can be considered as a two-
dimensional liquid where all lipid and protein molecules diffuse more or less freely.  In 
contrast to previous static representations of the biological membrane, the fluid mosaic 
model is dynamic and possesses the structural features that allow for communication 
between the extracellular environment and the cytosolic (intracellular) compartment via 
signal transduction and selective transport of solutes [7]. 
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1.2 TRANSPORT ACROSS PLASMA MEMBRANE: 
Because of the oily core, a pure lipid bilayer is permeable to only small 
hydrophobic solutes and the permeability of polar inorganic compounds and ions is very 
low.  This suggests that the cell membrane can only distinguish between solutes based on 
a few limited characteristics (e.g. size or number of hydrogen bonding groups).  
However, for the cell to allow easy access for specific metabolites from the environment 
and to facilitate easy removal of waste products, it must have greater flexibility of 
response than a simple lipid bilayer membrane can give.  This was demonstrated by the 
work of Overton et al., [12], and later by Collander et al.,  [13], where they examined the 
permeability of various solutes and found that small water-soluble molecules appeared to 
permeate the membrane more rapidly than could be accounted for on the basis  of their 
lipid solubility alone.  Additionally, Davson and Danielli et al.,[14]  showed that glycerol 
penetrates an erythrocyte membrane 100 times faster than predicted.  These observations 
led them to propose that membranes contain “active patches” which allow increased 
permeability of certain substrates across the membrane.   
This work was not limited to the movement of non-charged molecules across the 
membrane.  Throughout the 19th century, several groups were examining the electro-
chemical mechanism underlying nerve and muscle function.  The first group to suggest 
that ions move into and out of cells came from Carlo Matteucci when he suggested that 
tetanus toxin was somehow influencing the flow of ions into and out of muscle cells [15].  
Despite his observations, a sound mathematical explanation of this phenomenon 
remained elusive.  Further progress was made during the late 1880’s when Walter Nernst 
published his equations which allow for the calculation of the electrical potential of 
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selective biological membranes [16], followed by Wilhelm Ostwald’s suggestion that the 
electrical potential across artificial semi-permeable membranes was due to selective 
permeability of ions [17].  These observations culminated with the development of the 
“membrane theory” proposed by Julius Bernstein in 1902 [18].  In his landmark 
publication he proposed that 1.) Living cells are composed of an electrolytic interior 
surrounded by a thin membrane that is selectively permeable to ions. 2.) At rest, there is a 
pre-existing electrical difference (potential) across the membrane 3.) During activity, the 
ion permeability of the membrane increases, which reduces the potential to a 
comparatively low value [18]. 
 
1.3 IDENTIFICATION OF ION CHANNELS: 
Another significant advance in the study of ion transport came in 1940 when 
Webb & Young began studying ion currents in the squid giant axon [19].  The use of the 
squid giant axon as a model system for examination of ion transport resulted in Hodgkin 
& Katz concluding that the action potential was the result of the entry of sodium ions 
followed by an efflux of potassium ions from the cell [20].  However, the exact 
mechanism of how sodium passes through the cell membrane was not known.  The 
elucidation of this mechanism was greatly aided by the invention of the glass 
microelectrode [21] and the voltage clamp technique [22-24].  Using these methods, 
Hodgkin & Huxley were able to explain the action potentials in terms of movement of 
specific ions (K+, Na+, Cl-) through pores in axonal membranes, as well as demonstrate 
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that ion channels were fundamental to neuronal signaling [23].  These observations, and 
the use of radioactive tracer ions to track movement of ions across the plasma membrane, 
led to the commonly accepted idea that the ions were passing single file through a 
“narrow pore” or channel [23, 25]. 
In 1976, the development of the patch clamp method by Neher & Sakmann 
revolutionized the ability of physiologists to examine ion channels and how they function 
in cells [26].  Until then, researchers had only been able to study ion channels in neurons 
collectively (i.e. macroscopic currents).  The invention of patch clamping permitted the 
analysis of individual channels leading to characterization of different types of channels 
as well as deduction of some of their structural features.   
 
1.4 CURRENT VIEW OF ION CHANNELS: 
 The work of the researchers highlighted above as well as countless others, has led 
to the current view of ion channels as integral membrane proteins, or more typically, an 
assembly of several proteins that respond to a particular stimulus [3].  The common 
stimuli which activate ion channels include a change in membrane potential, a 
neurotransmitter (ligand binding), mechanical deformation or a second messenger such as 
cyclic adenosine monophosphate (cAMP).   
In general, ion channels contain several membrane-spanning domains which form 
a conduction pathway called “the pore”.  When a channel is open, the movement of a 
particular ion through the channel is influenced by two criteria.  The first is the 
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electrochemical gradient. The electrochemical gradient across the membrane actually 
consists of two gradients, the concentration gradient and membrane potential. The 
concentration gradient is the difference between ion concentrations on both sides of the 
membrane and the membrane potential refers to the electrical potential difference 
(voltage) across the membrane.  An example of ion movement through a selective barrier 
in response to the electrochemical gradient is shown in figure 1-2.  According to this 
model, ions will move down their concentration gradient from high to low.  Since ions 
are charged, their movement will be influenced by the concentration gradient as well as 
the electric field across the membrane (i.e. positive charge will be attracted to a negative 
charge and repelled by negative charges).  Thus, the total force on an ions movement will 
be determined by the combined effects of the electrical and chemical gradients.  From 
this model, it can be assumed that there will be some electrochemical potential at which 
the electrical force on the ion exactly balances the opposing force of the ion which is 
given by the Nernst equation. 
E=(RT/zF)*ln([out]/[in]) 
Where E is the equilibrium potential in volts, R is the gas constant (8.31 J K-1 mol-1), T is 
the temperature in degrees Kelvin, z is the charge of the ion and F is Faraday’s constant 
(9.64x104 C mol-1).  [in] & [out] are the internal and external concentrations of the ion 
respectively.   
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 Figure 1-2: Model of Electrochemical Gradient [3] 
In this model compartments A & B contain [High] and [Low] concentrations of positive 
ions.  If the barrier (membrane) separating A & B is made permeable to the positive ion, 
they will move down their concentration gradient from A to B.  The will result in an 
increase in the positive charge in B which will tend to oppose the movement of more 
positive ions.  Movement of ions from A to B will continue until the system reaches the 
equilibrium potential where the electrical gradient exactly balances the chemical gradient. 
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The second criterion that influences an ion’s movement is the relative 
permeability of the channel to a particular ion.  In most cases, ion channels do not act as 
pores that allow free diffusion of all ions; instead they function like molecular sieves 
showing considerable discrimination in the kinds of ions each channel allows to pass [3]. 
This can be appricated from the permeability ratio equation: 
Erev=(RT)/F*ln(PK[K]o + PNa[Na]o + PCl[Cl]i)÷(PK[K]i + PNa[Na]i + PCl[Cl]o) 
Using this equation is it possible to calculate the permeability ratios between different 
ions from measurements of reversal potentials, but not absolute permeabilities if ionic 
concentrations are known.  Where Erev is the reversal potential, R is the gas constant, T is 
the temperature in degrees Kelvin, F is Faraday’s constant, Px is the permeability of an 
ion, [X]o is the concentration of an ion outside of the cell and [X]i is the concentration of 
an ion inside of the cell. 
In addition to the general structural characteristics of ion channels, many channel 
properties have been deduced by recording single channel activity using the patch clamp 
technique.  A typical single channel current recording is shown in figure 1-3.  The data 
obtained from these recordings show that a typical stimulated channel opens for a short 
interval and then closes and opens again after a variable amount of time [27].  The 
process of transition from the open to the closed state (and vice versa) is known as gating.  
The amount of time that each channel remains open or closed is highly variable and is 
quantified as the open probability (Po).  The open probability is defined as the fraction of 
time the channel spends in the open state which can be calculated by dividing the sum of 
all the open times by the duration of the recording [3]. These characteristics have led to 
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the identification and classification of a large quantity of ion channels located in every 
cell type.       
 
 
 
 
 
 
Figure 1-3: Single Channel Currents Recorded using Patch Clamp. [3] 
When the channel opens ions move through it creating a tiny current shown as an upward 
deflection of the trace.  As shown here, a fixed membrane potential the amplitude of the 
single channel current is constant but the length of the time the channel remains open is 
variable. 
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1.5 ION CONDUCTANCE IN SECRETORY EPITHELIA: 
1.5.1 The Two Membrane Model. 
As the volume of ion channel research increased, it became evident that ion 
channels are present and function in many cell types, not just those cells deemed 
“excitable” cells such as neurons.  For example, studies on frog skin by Ussing and 
colleagues revealed that it would absorb sodium ions against a  100-fold concentration 
difference on the interstitial side [28].  This movement of sodium across the frog skin was 
shown to be dependent on the presence of sodium on the pond side and the presence of 
potassium on the interstitial side [28, 29].  These studies led to the proposal of the two-
membrane model for epithelial sodium uptake or the Koefoed-Johnsen-Ussing (KJU) 
model in 1958 [figure 1-4] [30].  In this model, the sodium uptake by an epithelium can 
be understood in the context of two membranes acting in series.  The outer membrane is 
permeable to H20 and sodium and the inner membrane is permeable to potassium and is 
where the pump, which exchanges cellular sodium for interstitial potassium, resides.  In 
the KJU model, the action of the pump limits the increase in intracellular sodium 
concentration achieving a steady state in which the cells will continue to import sodium 
as long as it can be supplied with Adenosine 5'-triphosphate (ATP) [30].  
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Figure 1-4: Koefoed-Johnsen-Ussing (KJU) Two membrane model of Epithelium sodium uptake. [31] 
A modernized view of the KJU model by polarized principle cells of the short-circuited 
amphibian epidermis from Lindemann et al., [31].  Amiloride sensitive Na+ channels are 
shown on the apical membrane facing the external environment.  K+ channels 
(rectangles) and Na+/K+ pumps (circles) are shown on the basal membrane facing the 
interstitial compartment.  
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1.5.2 NaCl absorption and secretion in epithelial cells 
Coinciding with the increased knowledge of ion channel diversity in different cell 
types, there has also been an increase in the knowledge and understanding of channels 
that pass ions besides Na+ & K+.  Following the development of the KJU model, research 
on the transport of other ions in the context of epithelial cells continued to develop our 
understanding of the mechanisms involved in ion movement across epithelium. Using 
small intestine and rabbit gallbladder as a model system, Frizzell et al., [32] developed a 
model of a neutral coupled NaCl influx where the apical membrane mediates the influx of 
NaCl from the environment in an electrically neutral fashion [32]. Based on their model, 
sodium and chloride entry into absorptive cells are linked at the mucosal membrane and 
the presence of 140mM NaCl (extracellular) resulted in a net influx of Na+ and Cl- which 
was eliminated by removal of either sodium or chloride from the apical solution [32]. 
Continued study of this mechanism led to the development of the proposed model 
of NaCl transepithelial movement in airway surface epithelium (figure 1-5).  In this 
model, normal physiological conditions would favor absorption of Na+, Cl- and H20 [33-
35] according to the previously proposed KJU model [30]. NaCl absorption requires the 
entry of Na+ ions through the apical surface sodium channel [36] which results in a 
depolarization of the apical membrane potential (Va) value resulting in an increase in the 
hyperpolarization of the membrane voltage (Vt) across the airway according to the 
formula: 
Vt=Vb-Va 
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Where (Vt) is the transepithelial electrical potential difference, Vb and Va are the 
basolateral and apical membrane potential differences respectively. This change in 
transepithelial potential (Vt) permits chloride absorption into the interstitial fluid by its 
movement through the paracellular pathway.  The sodium that enters the cell is 
subsequently extruded by the action of the Na+/K+-ATPase pump residing in the 
basolateral membrane [37].  The build up of intracellular K+ due to the function of the 
pump, which brings in 2 K+ for every  3 Na+ ions excreted, K+ is recycled out of the cell 
through potassium channels in the basolateral membrane.  The end result of this series of 
events is the transepithelial movement of NaCl from the mucosal environment through 
the epithelial cells and into the serosal environment in an electrically neutral fashion with 
H20 following along its osmotic gradient.  
In addition to NaCl absorption by surface epithelium, the proximal airway is also 
involved in salt secretion.  In contrast to NaCl absorption, the epithelial cells which are 
responsible for salt secretion in glandular structures lie deeper within the proximal airway 
than the airway surface epithelial cells [38], although airway epithelium can secrete NaCl 
if apical membrane Na+ conductance is inhibited [35, 39] [Figure 1-5A&B].  Chloride 
secretion in airway epithelia is a two step process that is regulated by increases in the 
intracellular cAMP concentration [40].  In this process, chloride enters the cell across the 
basolateral membrane by means of an electrically neutral sodium/potassium/2-chloride 
co-transporter (NKCC1) [41].  The action of NKCC1 along with the Na+K+-ATPase, 
allows for an increase in intracellular chloride concentrations above its electrochemical 
equilibrium, creating an electrical driving force for chloride exit across the apical 
membrane [42-46].  The subsequent movement of Cl- out of the cell through a cAMP 
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activated Cl- channel hyperpolarizes the apical membrane potential providing a strong 
driving force for Na+ exit via the paracellular pathway (figure 1-5) resulting in a net flux 
of NaCl from the serosal solution across the epithelium into the mucosal environment.   
Willumsen et al., [39] characterized this process in human nasal epithelium and 
determined the intracellular and extracellular concentrations of sodium and chloride to be 
(Na+i=22mM; Na+o=100mM; Cl-i=40mM; Cl-o=80mM) as well as an apical membrane 
potential of -25mv and a basal membrane potential of -35mV.  Using the equation for 
electrochemical driving force  
Δμi-o=(RT/zf) *(log[in]/[out]) +  (ϕi-ϕo) 
Where Δμ is the total driving force for an ion, R is the universal gas constant, T is the 
absolute temperature, f is Faraday’s constant, z is the valence of the ion, ϕi is the 
transepithelial electrical potential difference (Vt) and ϕo is the basolateral membrane 
potential difference (Vb).  Using their measured values, they reported a driving force for 
Na+ (-55mV) and Cl- (3.5mV) which favor absorption in airway epithelia.  However, 
when the apical Na+ conductance was blocked they observed hyperpolarization of both 
apical and basal membrane potentials to -36mV and -41mV and a Vt of -5mV.  From 
these values they determined that blocking the apical membrane Na+ conductance 
resulted in a -12mV driving force for Cl- secretion consistent with the model presented in 
figure 1-5B of chloride secretion in the proximal airway. 
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Figure 1-5: Model of cellular NaCl absorption and secretion [47]. 
Models of NaCl absorption and secretion in proximal airway.  A) Schematic of proximal 
airway showing sites of NaCl and water transport.  Expression of CFTR chloride channel 
indicated by shading.  B.) Cellular models for NaCl absorption in surface epithelium and 
secretion in serous cells of submucosal gland under open circuit conditions.  The apical 
Cl- channel shown in both models is CFTR.  Vt is lumen negative in both models with 
physiological solutions at both surfaces. 
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With the model for NaCl absorption and secretion firmly established, diseases 
which were thought to be the result of a defect in NaCl transport were examined.  A 
known characteristic of patients with the disease cystic fibrosis (CF) is a high NaCl 
concentration in the sweat which led to the expression, “Woe to that child which when 
kissed on the forehead tastes salty”.  Studies on isolated sweat glands from CF patients 
suggested that low Cl- permeability resulted in poor reabsorption of NaCl in the sweat 
duct resulting in an increase in the concentration of salt in the sweat [48, 49]. 
Knowles et al., [50, 51] reported that the nasal and bronchial epithelia of patients 
with CF had an increased basal transepithelial potential difference, treatment of the 
airway surface with amiloride (a blocker of Na+ transport) increased the transepithelial 
potential difference and that removal of Cl- from the airway surface resulted in a smaller 
Cl- diffusion potential difference.  These three characteristics of CF tissue indicated that 
the disease is the result of altered ion transport or permeability which results in deranged 
airway surface liquid volume and composition, thickened mucus and recurrent lung 
infections common in patients with cystic fibrosis [52].  Continued study of epithelia 
from subjects with CF showed that Na+ channel activity was significantly higher while 
the Cl- permeability was drastically reduced [49, 51] which left the actual defect in CF 
unknown (i.e. increased Na+ absorption or decreased Cl- permeability).   
Support for the CF defect being a decrease in chloride permeability came from 
studies by Widdicombe et al., [53].  In their studies, they compared the responses of 
normal and CF trachea cells to treatment with isoproterenol which had been shown to 
stimulate short circuit currents (Isc) across dog and human cells in culture [54, 55].  
Treatment of normal cells with isoproterenol resulted in an increase in transepithelial 
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potential difference and a depolarization of the apical membrane along with a decrease in 
the fractional resistance of the apical membrane indicating that isoproterenol stimulates 
chloride secretion by increasing Cl- permeability [53].  However, when CF cells were 
treated with isoproterenol no change in transepithelial potential difference, apical 
membrane potential or fractional resistance was reported suggesting that cystic fibrosis 
decreases apical  Cl- permeability [53].  
Although the evidence to implicate defective Cl- transport as the cause of cystic 
fibrosis was compelling, without identification of the mutated chloride transporter a 
conclusive disease model could not be developed.  Although the previous studies were 
unable to identify a specific chloride transporter, the identification of isoproterenol 
activation proved a useful diagnostic tool in the search.  Welsh et al., and Halm et al., 
[56, 57] identified apical chloride channels from human epithelium that were anion 
selective, stimulated by increasing intracellular cAMP, outwardly rectifying (larger 
outward currents than inward currents), and not sensitive to Ca2+.    Despite the efforts of 
the researchers involved none of these channels were able to be definitively shown to be 
“the cystic fibrosis channel”. 
Efforts to identify the “CF channel” using chromosome walking/jumping and 
complementary DNA hybridization isolated DNA sequences, encompassing more than 
500,000 base pairs on the long arm of human chromosome 7 which contained at least 
four transcribed sequences from a region thought to contain the CF locus [58].  Of the 
four segments, three were shown to not be the CF locus by DNA sequence analysis and 
the fourth segment was indicated as containing at least a portion of the cystic fibrosis 
gene locus [58-60].  Two DNA segments in the fourth segment were used as probes to 
 17 
screen cDNA libraries which led to the identification of an open reading frame on 
chromosome 7 capable of encoding a protein of 1480 amino acids with expression 
highest in those tissues which were severely affected by cystic fibrosis [1].  Additionally, 
when sequences derived from CF patients were compared to those from unaffected 
patients the deletion of a phenylalanine residue at position 508 was identified only in the 
CF patients [1].  These observations led Riordan et al., [1] to conclude that they had 
identified the cystic fibrosis gene and that the major genotype of cystic fibrosis patients 
was the deletion of a phenylalanine at position 508 (the mutation was designated ΔF508).  
From their findings, they proposed that the protein encoded was 1480 amino acids in 
length, contained two repeated motifs each capable of spanning the plasma membrane 12 
times, as well as two sequences that resembled ATP binding folds separated by a unique 
regulatory domain which contains multiple consensus phosphorylation sites (figure 1-6) 
[1].  The similarity of the nucleotide binding domains to those of the mammalian 
multidrug resistance P-glycoprotein suggested that the CF gene product is probably 
involved in transport across the plasma membrane [1].  They named the identified gene 
product the cystic fibrosis transmembrane conductance regulator (CFTR).    
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 Figure 1-6: Model of CFTR Structure [1]. 
The proposed structural model of CFTR has a cytosolic NH2 terminus leading into six 
membrane-spanning domains (MSD1) followed by the first nucleotide-binding domain 
(NBD1). A unique feature of CFTR is the cytoplasmic regulatory domain (R-domain) 
linking the NH2 and COOH halves of the channel, which contains multiple protein kinase 
A (PKA) phosphorylation sites.  The R-domain connects to six more membrane-spanning 
segments (MSD2), finally terminating in an intracellular nucleotide binding domain 
(NBD2), followed by the COOH terminus of the channel. 
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1.6 CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE 
REGULATOR (CFTR): 
1.6.1 CFTR & Cystic Fibrosis. 
Mutations in CFTR result in the disease cystic fibrosis, one of the most common 
human genetic diseases, affecting nearly 1 in 2500 people in northern Europe and the 
United States [3].  As of 2007, over 1500 CFTR mutations of various types have been 
identified (Table 1-1). The most important pathological abnormalities of CF occur in the 
lungs, where mucous accumulation leads to chronic infection, progressive tissue 
destruction, fibrosis and air trapping due to occlusion of the distal airways [61-64].  
However, cystic fibrosis pathology is not restricted to just the lungs, exocrine glands are 
also affected.  In the pancreas the lack of digestive enzyme secretion results in pancreatic 
insufficiency and malabsorption in the gut [65-68]. Additionally, cystic fibrosis can lead 
to obstruction or congenital absence of the vas deferens in males leading to infertility [69-
73].   
Mutation Type Count Frequency % 
Missense  652 41.85 
Frameshift  246 15.79 
Splicing  198 12.71 
Nonsense  150 9.63 
In frame in/del  31 1.99 
Large in/del  44 2.82 
Promotor  8 0.51 
Sequence variation  227 14.57 
 
Table 1-1: Categorization of detected mutations in CFTR according to the Cystic Fibrosis Mutation 
Database [74]. 
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 Mutations of CFTR that result in a CF phenotype are separated into four 
categories or classes based on their effect on channel function (Figure 1-7).  Class I 
mutations result in a lack of protein production as a result of splice site abnormalities, 
frame shifts caused by deletions and insertions or nonsense mutations.  Class II is 
characterized by a defect in trafficking resulting in a significant decrease in the amount of 
CFTR expression at the plasma membrane.  An example of this type of mutation is 
ΔF508 (the most common CFTR mutation) which is associated with minimal cAMP-
activated chloride conductance as a result of incorrect folding.  The misfolding of ΔF508 
results in its targeting to the Endoplasmic Reticulum Associated Protein Degradation 
(ERAD) pathway for  ubiquitination and subsequent degradation by the proteasome, 
preventing the channel from reaching the plasma membrane [75, 76].  Class III mutations 
are correctly processed but cAMP stimulation fails to elicit channel opening, such as the 
G551D mutation that occurs in NBD1, which results in a decrease in  ATP binding [77].  
Class IV is characterized by alterations in channel conduction properties which can occur 
by different means.  For example, R334Y and R347P result in a significant decrease in 
single channel conductance possibly through disruption of the channel pore, while 
R117H reduced chloride conduction by decreasing the Po of CFTR [78, 79].   
Although this classification system is very useful, it is not without limitations.  
For example, the most common CF causing mutation ΔF508 falls into more than one 
class.  As stated earlier, ΔF508 results in a channel that is misfolded thus preventing its 
trafficking from the ER to the plasma membrane typical of a Class II mutation.  Studies 
have shown that indeed some ΔF508 does escape the ER and moves to the plasma 
membrane where it can conduct chloride [80-88].  However, once at the membrane the 
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ability of the channel to conduct chloride is significantly reduced due to a decrease in the  
open probability (WT-CFTR Po=0.4; ΔF508 Po=0.1) leading to a decrease in the ICl at the 
apical membrane [84] which is characteristic of a Class IV mutation, indicating that a 
single CFTR mutation can adversely affect multiple steps in the proteins processing 
and/or function.   
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 Figure 1-7: Representation of Classes of CFTR mutations [89]. 
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1.6.2 CFTR and Anion Conduction. 
The primary sequence of CFTR has considerable homology to a family of 
proteins called ATP binding cassette (ABC) transporters.  They are one of the largest and 
most ancient protein families with representatives in all extant phyla from prokaryotes to 
humans. The family includes a large number of bacterial permeases and in eukaryote 
cells, the multi-drug resistance protein (p-glycoprotein) and the sulphonylurea receptor.  
ABC transporters are transmembrane proteins that function in the transport of a wide 
variety of substrates across extra- and intracellular membranes, including metabolic 
products, lipids, sterols and drugs. Proteins are classified as ABC transporters based on 
the sequence and organization of their ATP-binding domain(s), also known as nucleotide-
binding folds (NBFs). However, unlike bacterial ABC transporters, the individual 
domains of CFTR are not encoded by separate genes; all functional domains of CFTR are 
encoded by a single gene.   
Because of CFTR’s homology to other ABC transporters, initially it was believed 
that it was not an ion channel.  Following the cloning of CFTR, the first successful 
expression of the protein was in CF epithelial cells.  Although the expression of CFTR 
was able to correct the chloride channel defect [90, 91], it was believed that this effect 
was not the result of CFTR conducting chloride [92, 93].   However, when CFTR was 
expressed in various systems that do not normally express CFTR or have cAMP 
dependent chloride channels, cAMP dependent chloride currents were detected [94-96].  
Moreover, when Anderson and co-workers mutated CFTR they observed the anion 
selectivity of the channel was altered suggesting that CFTR is itself a channel, as opposed 
to it acting as a regulator of another channel [97].  Definitive evidence of CFTR being a 
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chloride channel was provided by reconstituting CFTR in planar lipid bilayers where a 
low pS, chloride selective ion channel activity was detected that was protein kinase A and 
ATP dependent [98, 99].  
With CFTR being firmly established as a Cl- channel, investigations into the 
biophysical properties of the channel were performed.  From an electrophysical stand-
point, CFTR channels possess several unique characteristics (Figure 1-8), such as 
regulation of channel activity by cAMP-dependent phosphorylation and intracellular 
nucleotides, a small single channel conductance of 6-10pS, linear current voltage 
relationship, time and voltage independent gating.  The channel is also selective for 
anions over cations with an anion permeability sequence of Br-≥Cl->I->F- [100].  In 
addition to being permeable to ions, CFTR was also shown to be able to conduct a large 
number of polyatomic anions in the sequence NO3->Cl->HCO3->formate>acetate [101].    
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Figure 1-8: Single Channel Recording and Current/Voltage relationship of WT-CFTR [102, 103] 
A) 5 sec. trace from excised inside-out patch containing 1 CFTR channel held at -80 
mV.  Stimulation with 75nM PKA and 1mM ATP. Dashed line is closed state [102].  B) 
current/voltage (I/V) relationship of channel at 35° C with symmetrical N-methyl-D-
glucamine chloride (140mM) [103].  
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1.6.3 CFTR Structure /Function: 
 
1.6.3.1 Nucleotide Binding Domains. 
One of the characteristic features of CFTR is that for the channel to open, the 
intracellular membrane surface must be exposed to (hydrolysable) ATP.  The coupling of 
CFTR gating to ATP hydrolysis occurs at the two nucleotide binding domains (NBDs).  
The binding of ATP to the NBDs results in conformational changes that open and close 
the channel and allow transmembrane flow of Cl- or HCO3 down its electrochemical 
gradient.   
The importance of the NBD’s of CFTR is emphasized by the number of disease 
associated mutations in these domains [2].  The highly conserved nucleotide binding 
motifs (Walker A & Walker B) and LSGGQ motifs (which stabilize ATP binding and 
catalyze its hydrolysis) of CFTR’s NBDs have been shown to bind and hydrolyze 
intracellular ATP respectively, to regulate channel gating [104, 105].  To discern the 
mechanism of NBD regulation of CFTR gating Anderson et al., [97] studied ATP 
regulated Cl- activity in excised inside-out membrane patches.  They found that addition 
of ATP to the intracellular solution had no effect, but once the channel was 
phosphorylated by PKA, the channels were activated suggesting that ATP regulates the 
channel only after it has been phosphorylated by PKA [97].  Further studies on 
phosphorylated channels revealed that as the ATP concentration increased, the mean 
closed time decreased but mean open time did not change which led to the proposed 
kinetic model of CFTR gating that consisted of two closed states and one open state 
[C1? ?C2??O] [105-109].   In this model the progression of activation first requires 
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the phosphorylation of CFTR in the C1 state, the transition from C1 to C2 requires the 
binding of ATP to the NBDs which then leads to channel opening.  
Further analysis of CFTR gating and the role of NBDs using homology models 
from several NBD crystals was performed by Vergani et al., [110].  As seen in figure 1-9 
in the model they propose, ATP binding to NBD1 triggers its binding to NBD2.  
Additional ATP binds to NBD2 which results in a slow opening of the channel (C2-to-
Open) through a transition state that requires the formation of the NBD1/NBD2 
heterodimer.  The open state of the channel is destabilized by the hydrolysis of ATP on 
NBD2, which results in disruption of the heterodimer NBD and leads to closing of the 
channel 
 
 
Figure 1-9: Model of nucleotide binding domain regulation of CFTR gating [110]. 
 
Diagram illustrating the proposed mechanism coupling the opening of channel pore in the 
transmembrane domains to the hydrolysis cycle through the dimerization of NBDs (Cn= 
Closed states O= Open state). 
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1.6.3.2 The R-domain: 
In addition to the above structures, CFTR also contains a unique stretch of amino 
acids located between NBD1 and TMD2 that contains multiple sites for PKA 
phosphorylation called the regulatory, or R-domain (Figure 1-10 & table 1-2). The 
boundaries of the R-domain have been up to some debate.  Originally, the R-domain was 
defined aa590-830 or those amino acids encoded by exon 13 [1].  However, severing 
CFTR after aa634 and before aa835 and co-expressing it as two half channels produced a 
functional channel which was constitutively active [111] indicating that the N- and C-
terminal boundaries of the R-domain are 634 and 835 respectively.   
The most obvious feature of the R-domain upon analysis of its sequence is the 
presence of multiple highly conserved consensus sequence sites for PKA 
phosphorylation.  Other than the phosphorylation sites, there is little sequence similarity 
between species of the remaining residues although there is a “conservation of charge” of 
approximately 28%  with sixteen of the 24 basic residues in the PKA sites and several are 
clustered between aa817-838 [112]. 
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 Figure 1-10: Summary of CFTR phosphorylation by cAMP-dependent protein Kinase A [113] 
Summary of CFTR phosphorylation by cAMP-dependent protein kinase (PKA).  
Illustrates relative levels of phosphorylation of individual sites observed (except for Ser-
768) after brief stimulation of PKA in intact cells, with relative contribution of each site 
to regulation of CFTR channel activity inferred from site-directed mutagenesis reflected 
by (+) or (-). Note distinction between stimulatory (+) = stimulatory site sites and 
inhibitory (-) = inhibitory sites.   
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Table 1-2: Biochemical and functional analysis of phosphorylation sites on the R-domain [113]. 
Residue 
Number 
Amino Acid 
Sequence 
In Vitro PKA 
Phosphorylation 
In Vivo PKA 
Phosphorylation 
Function 
discerned by 
Mutagenesis 
S660 RKTS √ ND ++ 
S670 RFS √ ND + 
S686 KKQSFK ND ND Nil 
T690 KQT ND ND Nil 
S700 KRKNS √√√ √√ + 
S712 RKFS √√ ND Nil 
S728 EDSDE ND ND Nil 
S737 RRLS √√√ √√√ --- 
S742 PDSEQ ND ND Nil 
S753 RIS √ √ + 
S756 VISTG ND ND Nil 
T757 ISTGP ND ND Nil 
T760 GPTLQ ND ND Nil 
S768 RRRQS √√√√ ND ---- 
T787 RKT ND ND Nil 
T788 RKTT ND ND Nil 
S790 STRK ND ND Nil 
S795 RKVS √√√√ √√√ ++ 
S813 RRLS √√ √√√√ ++++ 
 
In vitro data from amino acid sequencing, mass spectrometry, and kinetic analysis of 
phosphorylation of intact CFTR, of an R-domain peptide, and of short peptides derived from R-
domain sequences.  In vivo information comprises results from 32P labeling followed by 
immunoprecipitation and two-dimensional peptide mapping.  In all cases, indicated relative level 
of phosphorylation of a particular site reflects acute cAMP-dependent PKA mediated 
incorporation of 32P over a 5-15 min period.  Sites are indicated as stimulatory (+) when mutation 
caused rightward shifts of IBMX dose response curves and mutation of sites labeled inhibitory (-) 
caused leftward shifts but mutation of other sites (nil) had no effect.  √ indicates residue was 
phosphorylated by PKA; ND indicates phosphorylation by PKA was not detected, nil mutation 
had no effect. Number of (+), (-) or (√) indicate magnitude of effect. 
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Analysis of the PKA sites on the R-domain has shown that only five (ser-660; 
700; 737; 795; 813) appear to be readily phosphorylated by PKA in vivo in cells that 
express native or recombinant CFTR [114, 115].  Further analysis of the R-domain’s 
phosphorylation sites via site-directed mutagenesis and two-dimensional peptide mapping 
have shown that ser-660; 700; 712; 737; 753; 768; 795 and 813 may be phosphorylated in 
vitro by PKA when applied to R-domain peptides or NBD1-R-domain peptides [114-
118].  The ability of some of the serines to be phosphorylated in vitro while not being 
phosphorylated in vivo likely reflects variation in the kinetics of phosphorylation at each 
site which may be overcome by higher levels of PKA treatment for a longer period of 
time.   
 To determine which of the sites on the R-domain are important for regulation of 
CFTR, individual and groups of serine residues were mutated to alanine.  This series of 
experiments revealed that mutation of any one of the five readily phosphorylated serine 
residues or even groups of two to three did not have any effect on grossly measured 
cAMP-stimulated anion permeability [114, 119] indicating a functional redundancy 
where one particular site is not essential for proper R-domain regulation of CFTR.  
However, mutation of four or more serine residues resulted in a two-fold decrease in 
cAMP-stimulated iodide efflux and channel open probability (Po) [119, 120].  Further 
reduction in Po and anion conduction was observed when the eight in vitro 
phosphorylated serines were mutated to alanine.  Moreover, continued mutation of ten, 
eleven or 16 serine residues only slightly reduced cAMP/PKA induced channel activity 
compared to the eight ser/ala mutations [119, 120].  Taken together, these data clearly 
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indicate the PKA phosphorylation of at least eight of the serines on the R-domain of 
CFTR is required for optimal channel activity.  
 The reduction in channel Po due to mutation of serine residues suggested that 
when not phosphorylated, the R-domain acts as an inhibitory particle preventing Cl- 
conduction even in the presence of ATP.  This hypothesis was tested by a two-pronged 
approach using site-directed mutagenesis and examination of R-domain deletions.  
Csanady et al., [111], demonstrated that when the entire R-domain was deleted (aa634-
836), the result was a channel that was constitutively active and Po was only slightly 
increased by cAMP/PKA stimulation.  Furthermore, when this construct was treated with 
the PKA inhibitor Rp-cAMPSA, the elevated basal conductivity was not substantially 
reduced [111].   
Another approach used to examine the inhibitory property of the R-domain was 
site-directed mutagenesis, where individual serine residues were mutated to aspartic acid, 
mimicking phosphorylation at that residue.  Mutation of four readily phosphorylated 
serine residues (660; 737; 795; 813) did not result in an increase in the  basal chloride 
current when mutated individually or simultaneously [119].  Similar to the serine-to-
alanine mutations, which required eight point mutations to inhibit activity, no observed 
changes in channel function were observed with the serine-to-aspartic acid point 
mutations until eight amino acids (660; 686; 700; 712; 737; 768; 795; 813) were changed 
from serine to aspartic acid [119].  This S-oct-D construct was constitutively active and 
was able to be activated to a greater extent by the addition of cAMP to the channel. 
Under non-stimulated conditions, the prevailing view is that channel gating is 
inhibited by R domain elements that perhaps interfere with NBD dimer formation.  This 
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is similar conceptually to the ‘ball and chain’ model of Shaker K channel inactivation 
[121, 122], and this model is supported by the finding that addition of the non-
phosphorylated R domain to the cytoplasmic face of active CFTR channels is inhibitory 
[123].  Conversely, a stimulatory action of the R domain was implicated by the properties 
of CFTR channels bearing a large R domain deletion (708-835), which gate with reduced 
open probability, but are stimulated by the addition of a phosphorylated R region 
polypeptide (aa 645-835) [124].  It also appears that the location of the R domain, at the 
center of the repeated ABC structure, is not critical to channel regulation, since its 
transplantation to the C-terminus of CFTR, together with a sufficient linker region, also 
confers regulated CFTR channel function [125].       
Taken together, these data fit the model of R-domain regulation proposed by 
Chappe et al.,[126]  in which they describe the R-domain as having both a stimulatory 
and inhibitory function depending on its phosphorylation state (figure 1-11).  When 
unphosphorylated, the R-domain is bound to a site on the channel which indirectly blocks 
the flow of Cl- through the channel, possibly by blocking NBD dimer formation.  
Phosphorylation of the channel results in the movement of the R-domain away from the 
pore where it associates with a stimulatory site permitting chloride conduction.   
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 Figure 1-11: Model of effect of phosphorylation of the R-domain of CFTR [126] 
In this model following the NBD1/NBD2 dimerization, PKA phosphorylates the R-
domain which results in its interaction with the N-terminus of the channel allowing for 
anion conduction. 
 
 
 
 
 
 
 
 35 
1.6.4 Regulated CFTR Trafficking: 
 Much attention has been focused on elucidating the mechanisms which regulate 
CFTR’s ability to conduct chloride ions.  Although regulation of channel gating is a 
critical element in the regulation of CFTR it is not the only component of a system that 
regulates the channels response to stimulation.  This is evident from the formula for the 
total current. 
I=iNPo 
This identity states that the total current (I) is a product of (i) the single channel 
conductance, open probability (Po) and the number of channels in the membrane (N).  
This leads to the central question of regulated CFTR trafficking: Is the CFTR that 
contributes to plasma membrane chloride conduction present only in the apical 
membranes or does at least a portion of the channels reside in a sub-apical compartment 
from which it is mobilized to the surface following stimulation.   
 Studies of CFTR localization in cells provided support of the hypothesis of 
regulated CFTR trafficking.  Lehrich et al., [127] examined the shark rectal gland using 
confocal microscopy in order to study the localization of CFTR under basal and 
stimulated conditions.  When no agonist was present, they reported CFTR 
immunofluorescence from the apical membrane and extended into the sub-apical and 
supernuclear regions.  Stimulation with secretagogues resulted in movement of the signal 
toward the apical membrane resulting a decrease of the depth of CFTR signal by ≈50%  
[127].  Quantification of CFTR fluorescence intensity as a function of distance from the 
apical membrane confirmed the movement of the signal toward the apical membrane. 
Additionally, it has been shown that the vasoactive intestinal peptide (VIP) produced a 
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redistribution of CFTR to the apical membrane domain in rat small intestine [128].  
Using F-actin as a brush border marker in duodenal villus cells, VIP elicited a reversible 
three-fold increase in brush border associated CFTR  with the channel being redistributed 
within the cell apex to the plasma membrane within 30 min [128, 129]. 
 Subsequent studies of regulated CFTR trafficking examined the endo- and 
exocytic properties of CFTR expressing cells.  Prince et al., [130], using biotinylation of 
carbohydrate residues on the extracellular surface of T84 cells followed by 
immunoprecipitation and radioisotope labeling using [32P]-ATP found that CFTR was 
rapidly internalized by T84 cells with a half time of ≈3 min [130].  They also reported 
that cAMP stimulation resulted in an approximately  60% decrease in CFTR endocytosis.  
Moreover, they reported a small increase in apical membrane CFTR of ≈12%.  However, 
the method they employed might have had serious limitations on its ability to detect 
phosphorylated CFTR.  That is to say that using in vitro phosphorylation to detect CFTR 
following biotinylation and immunoprecipitation may be hindered by the phosphorylation 
state of the protein (i.e. if CFTR is phosphorylated by agonist there may be limited 
phosphorylation sites available for the in vitro phosphorylation assay) reducing the 
observed CFTR signal. To overcome this, Lukacs and co-workers developed a method 
for detecting CFTR where immunoprecipitation of the biotinylated CFTR was achieved 
with M3A7 and L12B4 monoclonal anti-CFTR antibodies [131].  Using this method they 
were able to show a forskolin-dependent inhibition of CFTR endocytosis and increase in 
plasma membrane CFTR as well as a depletion of the channel from intracellular 
compartments [131].   
 37 
 Studies of CFTR exocytosis have also demonstrated regulated channel trafficking 
in response to cAMP/PKA stimulation.  Pulse labeling the plasma membrane of cells 
expressing WT-CFTR with biotinylated lectin showed that cAMP/PKA stimulation 
increased the rate of exocytosis of internalized marker nearly three-fold and required the 
expression of CFTR [132].  Moreover, when recycling/exocytosis was examined in 
human airway cells via monitoring the release of previously internalized FITC-dextran 
treatment of cells expressing WT-CFTR with a cAMP analog resulted in an increase in 
the release of FITC-dextran which was accompanied by an increase in membrane 
capacitance when monitored by whole cell patch-clamp measurements [133].   
 In addition to the biochemical analysis of regulated CFTR trafficking, a 
substantial amount of work has been done to elucidate this process by using 
measurements of membrane capacitance which are summarized in table 1-3.  
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Table 1-3: Measurement of stimulated capacitance in CFTR expressing cells [4].  
Cell 
Type 
Method ΔCm Agonist Reference
Xenopus 
Oocyte 
2-
electrode 
voltage 
clamp 
(single 
sine wave) 
14nF 
100μM 
8-CPT-
cAMP 
1mM 
IBMX 
[134] 
Xenopus 
Oocyte 
2-
electrode 
voltage 
clamp 
(single 
sine wave)
23nF 
100μM 
8-Br-
cAMP 
1mM 
IBMX 
[135] 
Xenopus 
Oocyte 
2-
electrode 
voltage 
clamp 
(step) 
80nF 
10μM 
FSK 
1mM 
IBMX 
[136] 
9HTE0- Whole 
Cell 
Patch 
Clamp 
14pF 
100μM 
8-Br-
cAMP 
 
[133] 
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  Multiple studies have demonstrated that CFTR, expressed in the oocytes of the 
African claw-toed frog Xenopus laevis, produces a significant increase in chloride current 
with a corresponding increase in membrane capacitance following cAMP/PKA 
stimulation [135-137].  Takahashi et al.,[136] also demonstrated that the increases in Cm 
were accompanied by an increase in membrane surface area measured via morphometry.  
Along these lines, Peters and co-workers used a FLAG tagged CFTR construct expressed 
in Xenopus oocytes and were able to demonstrate recruitment of CFTR to the cell surface  
which corresponded to their observed increased in Cm [137].  Additionally, using 
impedance analysis to examine the effects of cAMP/PKA stimulation on ICl and Cm, 
Weber et al., [135] verified the previous results [136, 137] which showed a cAMP/PKA 
dependent increase in both parameters (ICl & Cm) [135].  Furthermore, they observed that 
these increases were not produced by cAMP/PKA in non-injected or ΔF508 expressing 
oocytes and that injection of the cAMP inhibitor (Rp-cAMP) abolished the cAMP/PKA 
induced increases in ICl and Cm [135].  Increases in plasma membrane CFTR density were 
also detected using atomic force microscopy (AFM) applied to membrane fragments 
excised from Xenopus oocytes expressing CFTR (25,26).  
These findings, together with the unitary relationship between the surface area 
and the electrical capacitance of biological membranes (1μF/cm2) [138], are consistent 
with the concept that cAMP/PKA stimulation elicits the fusion of CFTR-containing 
vesicles from intracellular compartments with the plasma membrane.   Taken together, 
these results indicate that in addition to regulating channel gating, cAMP agonists also 
modulate the density of CFTR channels in the plasma membrane in many systems [133-
137, 139-143].  Accordingly, the cAMP/PKA-induced increase in anion current 
 40 
associated with phosphorylation-dependent increases in CFTR open probability (Po) is 
supported also by an increase in the number of channels (N) resident in the surface 
membrane (22). The collected work from laboratories utilizing different cell types has 
suggested that this regulated trafficking function of CFTR is more significant in some 
systems than others; nevertheless, the trafficking pathways and associated protein 
interactions that underlie this response remain poorly defined.  
In the present study, we examined the structural basis of regulated CFTR 
trafficking using a series of CFTR deletion constructs, by assessing their cAMP/PKA- 
induced membrane current and capacitance responses. Our goal was to determine 
whether there were regions of CFTR that were required for its cAMP/PKA-dependent 
membrane trafficking. We found that the removal of the R domain from CFTR, in 
addition to producing a spontaneous Cl current in the absence of stimulation, eliminated 
the cAMP/PKA-induced membrane capacitance increase. In addition, both agonist 
stimulation and removal of CFTR’s R domain significantly reduced the channel’s 
functional half-life, implying that these conditions, which bring CFTR to the cell surface, 
also increase its exposure to degradation pathways. Structure-function analysis of R-
domain deletion constructs showed that removal of its C-terminal region produced a 
channel that retains agonist-dependent current regulation, but eliminated the cAMP/PKA-
mediated increase in Cm. These findings suggest that this ordered R domain segment can 
stabilize CFTR within intracellular compartments, whereas R domain phosphorylation, 
by interfering with this stabilization, permits a redistribution of CFTR to the cell surface 
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2.0  MATERIALS & METHODS: 
 
2.1 XENOPUS OOCYTES: 
Xenopus oocytes are egg precursors from the African claw toed frog Xenopus 
laevis that can pass through the female frog’s oviduct and be fertilized to develop into 
another frog.  An individual oocyte is a large cell with a diameter of approximately 1-1.2 
mm, surrounded by a glycoprotein matrix (vitelline membrane) which gives the oocyte 
some amount of structural stability and helps maintain its spherical shape [144].   
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 Figure 2-1: Individual stage V or VI oocytes from Xenopus laevis [144] 
 
The most obvious feature of a Xenopus oocyte is its two-toned color scheme; the 
animal pole is dark (brown) and the vegetal pole is light (yellow) [figure 2-1].  This 
polarization is maintained inside the oocyte, in that the nucleus is found in the animal 
pole and there are different populations of mRNAs in each pole.  Because Xenopus 
oocytes contain very few types of endogenous channels and receptors, they are an ideal 
system in which to study ion channel function. 
Gurdon and co-workers were among the first to use the unfertilized oocytes from 
the Xenopus laevis as an expression system to study gene expression [144].  They 
demonstrated that injection of haemoglobin mRNA into the nucleus or mRNA into the 
cytoplasm resulted in the expression of a functional protein.  The potential for the use of 
Xenopus to study ion channels was not realized until Miledi and co-workers showed that 
when ion channel cRNA was injected into oocytes, they produced a functional channel 
[144].  
 From these initial experiments, the use of Xenopus oocytes to study ion channels 
has expanded to examine various aspects of ion channel structure and function.  
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According to Axon Instruments [144], the use of Xenopus oocytes includes, but is not 
limited to: 1.) analysis of the properties of mutated channels 2.) analysis of receptor-
effector coupling 3.) screening of cloned ion-channel genes 4.) comparison of ion-
channel properties from various tissues expressed in common environment 5.) 
examination of multi-subunit assembly and post-translational processing of ion channels 
6.) studies of the effects of second messengers on channel function. 
 Because oocytes contain a layer of follicle cells surrounding the vitelline 
membrane, individual oocytes must be separated from the follicular cells.  Typically, this 
involves an extensive collagenase treatment to completely strip off the follicle cells.  This 
is done by immersing the oocytes in a calcium free saline solution containing collagenase 
for one to three hours, until approximately half of the oocytes have been removed from 
the ovarian lobe.   Once the oocytes are separated from the connective tissue, they are 
then sorted according to developmental stage.  An oocyte exists in one of six 
developmental stages (I-VI), where only the more highly developed stage V and VI 
oocytes are sorted out and used for expression of a particular cRNA due to their high 
expression of translation machinery.   
2.2 OOCYTE PREPARATION:  
Isolation and cRNA injection of oocytes was performed as described previously 
in Cunningham et al., [145], and Gurdon et al., [146].  Female Xenopus laevis were 
purchased from Xenopus I (Ann Arbor, MI).  When oocytes were to be extracted, the frog 
was anesthetized in a solution that contained 1.5L dH2O and 1.8g of trichina [ethyl-3-
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aminobenzoate methanesulfonic acid] and 4g Na-bicarbonate (Sigma-Aldrich, St. Louis, 
MO). This solution was then brought to 2L by the addition of ice.  Individual frogs were 
placed into the solution for a minimum of 1 hour.  Following incubation in the anesthetic, 
the frog was brought out and placed on a tub of ice with its head covered in ice.  To 
remove the oocytes from the frog, two one-inch incisions were made in the frogs starting 
from the lower pelvis to the middle of the thorax at about 45˚.  This exposed the 
underlying muscle layer which was cut with scissors to reveal the ovaries.  Each ovary 
was removed through the incision with forceps and placed in non-sterile 1X Modified 
Barth’s Solution (MBS) (table 2-1).  This protocol was approved by the University of 
Pittsburgh Institutional Animal Care and Use Committee.   
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Table 2-1: Solutions Used. 
ND-96  
 
96 mM NaCl, 1mM KCl, 1.2mM 
CaCl2, 5.8mM MgCl2, 10mM N-2 
hydroxyethylpiperazine-N’-2-
ethanesulfonic acid (HEPES) 
Modified Barth's Solution (MBS) 
(10X) 
879 mM NaCl; 10mM KCl; 24mM 
NaHCO3; 8mM MgSO4*7H2O; 
3mM Ca(NO3)*4H20; 4mM 
CaCl2*2H2O; 100mM HEPES (½ 
Na salt) 
MBS++ (10X) 
Above plus: 25mM Na-Pyruvate; 
500mg/ml penn/strep; 50ml horse 
serum/L 
Forskolin 10 mM stock in EtOH; Used at 10mM 
IBMX 500mM stock in DMSO; Used at 1mM 
C7-intracellular Buffer 
255 mM Potassium Glutamate; 
10mM NaCl; 14mM MgSO4; 
40mM HEPES 
Isoproterenol 10mM stock in DMSO; Used at 10mM 
Propranolol 100mM stock in DMSO; Used at 100nM 
Ca2+ - Free ND-96 (10X) 
959 mM NaCl; 10mM KCl; 10mM 
MgCl2*6H2O; 50 mM HEPES (½ 
Na salt) 
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 The isolated ovaries were placed in a large weigh boat filled with non-sterile 
MBS and cut into small pieces.  The cut ovaries were then placed into 6ml of collagenase 
solution (200mg/12ml Ca2+- Free ND-96) until the volume of the tube reached 10ml.  At 
this point, the oocytes were placed on an orbital rocker for 50 minutes at room 
temperature.  While the oocytes were being treated with collagenase, a hypertonic 
solution of 250 mM KH2PO4 was prepared (200ml 250 mM KH2PO4 + 200mg BSA) and 
placed on a stir plate.  Following the collagenase treatment, oocytes were washed three 
times with the KH2PO4/BSA solution to remove collagenase, the presence of BSA gives 
the remaining collagenase another substrate to react with in order to minimize any 
additional effects on the oocytes.  After the third wash the oocytes were bathed three 
times for five minutes in the KH2PO4/BSA solution without being disturbed in order to 
shrink any vasculature on the outside of the oocytes remaining following isolation.  After 
the washes in hypertonic solution, the oocytes were washed three more times with 1X-
Ca2+ Free-ND-96 (table 2-1) followed by 1 wash with MBS++ (table 2-1).  Following the 
wash in MBS++, the oocytes were placed in a 100mm Petri dish, filled with MBS++ and 
allowed to incubate at 18˚ C for a minimum of 2 hours prior to sorting individual oocytes.  
Stage 5 & 6 oocytes were isolated in a 100mM petri dish containing 1X MBS++ under a 
dissecting microscope. The sorted oocytes were then placed at 18˚ C overnight in MBS++.  
2.3 cRNA INJECTION AND EXPRESSION: 
cRNA was produced using the mMESSAGE MACHINE™ cRNA production kit 
from Ambion (Huston, TX) according to manufacturer’s suggestions (see section 2.4) 
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and then injected into oocytes for expression.  To accomplish this, we followed a 
modification of the protocols described in Cunningham, et al., [145], and Gurdon, et al., 
[146].  In our protocol, we injected cRNA constructs into oocytes in 50nl volumes using 
a micro-injection apparatus (World Precision Instruments, Sarasota, FL).  Injections were 
performed using RNAse-free glass pipettes which had the tips broken to the desired 
diameter using forceps.  The glass pipette was backfilled with mineral oil and placed in 
the micro injector.  The apparatus was then placed in position, and the cRNA to be 
injected was drawn up into the pipette.  To obtain the desired amount of cRNA to be 
injected, we diluted the stock cRNA using DEPC-treated H20 (Ambion, Houston TX).  
When multiple cRNAs were to be injected, they were co-injected into the oocyte in the 
same 50nl volume.  Following injection of cRNA the oocytes were placed in one well of 
a six well plate depending on which cRNA(s) were injected and allowed to incubate for 
1-3 days at 18˚ C to allow for maximal expression.    
2.3.1 Co-injection of NEG2 peptides 
The NEG2 peptide, derived from the C-terminus of the R domain and two 
modified peptides sNEG2 and hNEG2 (see Figure 3-9D), were synthesized via solid-
phase peptide synthesis (SPPS), and kindly provided by Dr. Robert Bridges (Rosalind 
Franklin University).  Each peptide was solubilized at a concentration of 50 μM in an 
intracellular buffer [147] containing (mM): 128 K glutamate; 5 NaCl; 7 MgSO4; 20 
HEPES; pH 7.0, titrated with ultra pure KOH), aliquoted and stored at -20˚C.  Oocytes 
expressing ΔNEG2-CFTR were voltage clamped as described in section 2.7 and allowed 
to equilibrate for 5 min.  NEG2, or a modified peptide, was drawn into an injection tip 
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similar to that used for cRNA injections, the clamp was interrupted, and oocytes were 
impaled and injected with 23 nL of NEG2 peptide solution.  Twenty minutes following 
peptide injection, experimental recordings were initiated using the standard agonist 
addition and recording protocols described in section 2.7.   
 
2.4 cRNA SYNTHESIS: 
In our experiments, we injected cRNA into individual oocytes for protein 
expression.  Because most eukaryotic mRNAs have 7-methyl guanosine cap structures at 
the 5’ end, these RNAs can be synthesized using the SP6, T3 or T7 polymerases via in 
vitro transcription reactions by including the cap analog (m7G(5’)ppp(5’)G) in the 
reaction.  To perform the reaction, the double-stranded DNA was linearized with the 
XHO-1 restriction enzyme (New England Biolabs, MA) that cut the DNA 3’ to the end of 
the coding sequence.  When linearized, the template was purified by phenol/chloroform 
extraction and ethanol precipitation.  The linearized DNA was then used as a template to 
synthesize cRNA using the mMESSAGE MACHINE™ kit from Ambion (Houston, TX) 
according to the manufacturer’s instructions.  For CFTR preparation, a double reaction 
was used to give a higher cRNA yield.  Briefly, the in vitro transcription reactions 
contained a mixture of linearized DNA template, ribonucleotide mix, cap analog and 
SP6, T3 or T7 RNA polymerase, as appropriate.  Following cRNA production, the 
remaining DNA template was degraded by the addition of DNase and cRNA was 
recovered by lithium chloride extraction and precipitation with ethanol and isopropyl 
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alcohol.   The concentration and purity of cRNA was examined by spectrophotometric 
measurement and gel electrophoresis. 
2.5 MOLECULAR BIOLOGY: 
For all of our experiments, the human WT-CFTR in the pBQ expression vector 
was used as a template.  CFTR deletion constructs were generated by polymerase chain 
reaction (PCR) using this template and various primers (Invitrogen, CA).  For deletion 
constructs, forward (deletion fwd) and reverse (1480 rev) primers were designed which 
bound to either the 3’ or 5’ end of the CFTR cDNA in pBQ.  These primers also had a 
restriction digestion site at the 3’ end of each primer (KPN1 on forward primer & XHO1 
on reverse primer) (figure 2-2A).  Either one of these primers was used in conjunction 
with another forward or reverse primer to generate a deletion at the desired site on CFTR 
using the 3-temperature PCR protocol shown in figure 2-2B.  Following the PCR 
generation of our deletion construct, it was then subcloned into the vector pcDNA3.1-V5-
His/Topo (Invitrogen, CA) using a topo-cloning kit according to manufacturers 
instructions.  This system uses topoisomerase attached to the open ends of the pcDNA3.1 
vector to subclone in a desired DNA fragment or PCR product.  Once the DNA was 
inserted into the vector it was transformed into top-10 competent cells (Invitrogen, CA), 
and 100 μl was plated on LB-AMP plates (100mg ampicillin/L of LB agar) and grown 
overnight at 37˚ C.  Following incubation, individual colonies were selected and used to 
seed 5ml liquid cultures in LB/AMP (10μl of 100mg/ml ampicillin per 5ml LB-broth).  
These cultures were then shaken at 37˚ C overnight.  When the cultures had reached log-
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phase growth 1ml of each sample was removed and used in a spin-mini-prep plasmid 
DNA isolation kit (Qiagen, CA).  The isolated plasmid DNA was used to in a series of 
restriction digests to assess the size and orientation of the inserted PCR product. The 
three restriction digestions that were performed on each sample were 1.) XHO-1 2.) 
KPN-1 3.) XHO-1+KPN-1; with restriction enzymes from (New England Biolabs MA), 
This allowed for determining the correct size of the insert as well as ensuring that the 
topo-sub-cloning placed the insert in the correct orientation.  In figure 2-2C the result of 
the restriction digests are shown on a sample of DNA that was generated via the above 
PCR protocol.  In this example, lanes 1-3 and 7-9 are the result of PCR generated mutant 
being inserted in the correct orientation in that only the double digest with KPN1 & 
XHO1 were able to excise a band of the proper size from the vector.  The digests in lanes 
4-6 show the results of the PCR fragment being inserted in the wrong orientation, since 
each enzyme results in excision of the PCR fragment from the vector.   
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 Figure 2-2: Overview of PCR protocol used to generate R-domain deletion constructs. 
A) Representation of primer design used to generate R-domain deletion constructs where 
the forward primer contains a KPN-1 site and the reverse primer contains a XHO-1 site to 
allow for analysis of orientation.  B) Three temperature PCR protocol used for generation 
of deletion constructs.  C) Restriction digestion analysis of orientation of insertion of R-
domain deletion construct generated by PCR.   Correct orientation is indicated by a 
double band only in the KPN-1/XHO-1 double digest (i.e. lane #3 & #9) (see text for 
description)   
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When the band size and orientation were assured, we used the remaining bacterial culture 
to seed a 50ml liquid culture for bulk plasmid isolation using a midi-prep plasmid DNA isolation 
kit (Qiagen, CA).  Following bulk isolation of the plasmid DNA, we then used 
phenol/chloroform extraction of the DNA to remove any impurities in the sample.  The clean 
sample was then sequenced at the University of Pittsburgh DNA Core sequencing facility.  The 
sequencing of each produced deletion construct provided definitive proof that the deletion was in 
the desired location as well as determine if any undesired mutations had been inserted into the 
construct during the PCR process.  Finally, the cDNA of the deletion construct was used as a 
template to produce cRNA for oocyte injection or transfected into mammalian cells as the 
experiment required. 
2.6 LUMINOMETRY: 
Labeling of CFTR at the cell surface utilized an externally epitope tagged CFTR 
construct (EXT-CFTR, [148]), kindly provided by Dr. John Riordan (UNC-CH).  HEK 
293 cells were transiently transfected with cDNA constructs encoding EXT-CFTR or WT 
CFTR (control), 4μg/35mm dish, 24 h prior to experiments using lipofectamine 2000 
(Invitrogen, CA) according to the manufacturers instructions.  Following transfection, 
cells were incubated in HEK 293 media (DMEM + 10% FBS) at 37˚ C overnight.  Cells 
were stimulated with 10 μM forskolin (EMD Biosciences, CA) at 37oC for 12 min and 
placed on ice.  For oocyte studies, EXT-CFTR (10ng) or WT CFTR (1ng) cRNA was 
injected together with β-AR and incubated in MBS++ for 3 days at 18˚C.  Oocytes were 
stimulated with 10 μM isoproterenol (Sigma, MO) as in the electrophysiological studies.  
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Non-stimulated HEK cells or oocytes, treated identically except for agonist additions, 
served as controls.  For chemiluminescence measurements, cell surface EXT-CFTR was 
labeled by sequential incubations in primary monoclonal HA antibody (1:1,000, 90 min) 
[Covance, New York, NY], secondary biotin-conjugated goat anti-mouse IgG (1:200, 90 
min) [Invitrogen, Eugene, OR], and streptavidin conjugated to HRP (1:500; 90 min) 
[Zymed, San Francisco, CA].  All steps were performed at 4°C to block CFTR 
trafficking.  The cells were then washed extensively, HRP-labeled proteins were detected 
using SuperSignal West Femto chemiluminescent substrate (Pierce).  This process 
involves the oxidation of luminal by hydrogen peroxide which is catalyzed horse raddish 
peroxidase (HRP), resulting in the  creation of an excited state product (3-
aminophthalate), which decays to a lower energy state by releasing photons.  The photons 
released were read in a TD20/20 luminometer (Turner, Sunnyvale, CA). 
2.7 TWO ELECTRODE VOLTAGE CLAMP: 
 To record currents from Xenopus oocytes injected with CFTR cRNA, we used the 
two electrode voltage clamp technique (2EVC).  A diagram of a conventional 2EVC is 
shown in figure 2-3.   
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 Figure 2-3: Conventional two electrode voltage clamp [144]. 
V1: voltage sensing microelectrode; I2 current passing microelectrode; SENSE: bath 
ground electrode voltage V1 for ground; Ibath; ionic carrier electrode to make the SENSE 
close to GND for current I2 ground.  Rb1 and Rb2 are series resistances between cell 
membrane and the bath electrodes Ibath and SENSE.  Vcmd: command voltage generated 
by computer.  Rm: membrane resistance. Cm; membrane capacitance. Rs: series resistance 
from the bath solution and recording system. 
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Oocytes were impaled with two 3M KCl-filled electrodes which were connected 
to a GeneClamp 500 amplifier (Axon Instruments, CA) via Ag-AgCl pellet electrodes 
and referenced to the bath by two Ag-AgCl pellet bath electrodes.  The voltage clamp 
was controlled by an AXOLAB 1100 analog-to-digital/digital-to-analog interface board 
(Axon Instruments, CA) using a modification of the pClamp-5 software (described in 
section 2-7-1) which was generated by Takahashi & Qi et al., [136, 149]  For our 
experiments, the membrane potentials were allowed to stabilize prior to starting to record 
current and capacitance.   
Using the voltage clamp technique requires the membrane potential to be held 
constant (clamped) while measuring the current flowing across the membrane at that 
voltage.  Our system (figure 2-3) used two different electrodes to measure the potential 
(V1) and pass current (I2).  The membrane potential (Vm) was recorded by the amplifier 
(A1) connected to the voltage sensing electrode (V1).  The Vm was then compared to the 
command potential (Vcmd) of the amplifier (A2) which was generated by the digital-to-
analog interface board using the modified pClamp-5.  A2 output was proportional to the 
difference between Vm and Vcmd, which forced current to flow through the current 
passing electrode (I2) to nullify the difference.   
 During recording of Xenopus oocytes or any large cell, the membrane current is 
sufficiently large so as to cause a significant drop across the resistance of the ground 
electrode.  Given that the potential recorded by V1 is the sum of the transmembrane 
potential (Vm) and the bath potential (Vb, potential across Rb1), then to accurately record 
Vm the value of Vb had to be zero or nearly zero or the value of Vb had to be 
independently measured and subtracted  from the potential recorded by V1.  To 
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accomplish this, we used a two electrode virtual ground circuit.  In this configuration, one 
ground was designated as the “sense” or voltage sensing electrode was placed near the 
cell surface.  There was no current flow through the “sense” electrode, thus eliminating 
any voltage drop across Rb2.  The other ground electrode (Ibath) carried ionic current in 
our system.  These two electrodes worked in a feedback loop along with A3 to ensure 
that the potential at the “sense” electrode is equal to the potential at the negative amplifier 
input (GND).  
 In the repetitive pulse protocol (figure 2-4B), Vm was held at -30 mV, approximating the 
Cl- equilibrium potential, and pulsed to -40 mV (50 ms) to obtain Cm, as described (section 2-7-
1).  To Measure Im, Vm was returned to -30 mV (100 ms) and then pulsed to -60 mV (200 ms) to 
obtain the reported transmembrane current, Im, which was sampled 10 ms before the end of each 
pulse.  This protocol was repeated every 5 sec throughout the experiment.  Using this protocol 
we were able to record CFTR-dependent Cl- currents and membrane capacitance from 
Xenopus oocytes.  
2.7.1 Capacitance Measurements: 
 A capacitor can be defined as two parallel conducting plates of large area 
separated by a thin sheet of insulator.  The thickness (≈10nm) and amphipathic nature of 
the lipid bilayer make them an excellent approximation of a parallel plate capacitor.  
Capacitance is measured in Farads, which is defined as the ratio of the magnitude of the 
charge on either conductor to the magnitude of the potential difference between them.  
The general formula for capacitance is: 
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Q=CΔV 
where (Q) is the charge, (C) is capacitance, and ΔV is the change in voltage.  Since 
charge is only stored in a capacitor when there is a change in voltage across the capacitor, 
the current flow through the capacitor is proportional to the voltage change with time.  
This can be expressed in terms of current by the following equation: 
I=C(ΔV/Δt) 
The stored charge on the membrane capacitance approximates the resting potential in that 
any change in voltage across the membrane is accompanied by a change in stored charge 
[144].  This indicates that if a current is applied to the membrane, it must first satisfy the 
requirement for charging the membrane capacitance, and then it can change the 
membrane voltage.  This can be graphically represented by depicting the membrane as a 
resistor of value (Rm) in parallel with capacitance (Cm) [Figure 2-4].   
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B  
 
 
Figure 2-4: Model of biological membrane as an RC circuit [144] 
A) This model of a biological membrane clearly indicates that if a current pulse is 
applied to the circuit it must first charge the capacitance only then can the voltage 
change to a steady state value. B) Model of our 2EVC pulse protocol used during our 
experiments to measure Im and Cm.  First pulse to -40mV was used to calculate Cm 
and the second pulse to -60mV was used to measure Im. (see text for details)   
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The requirement of charging the membrane in response to an induced current 
prior to a change in voltage indicates that a time element must be taken into account. The 
charging of the membrane is approached along an exponential time course of: 
V(t)=Vinf(1-e-t/τ) 
where Vinf is the infinite time or equilibrium value and does not depend on the 
capacitance.  Instead it is determined by the current (I) and the membrane resistance 
(Rm), which can be represented by Ohm’s law: 
Vinf=IR 
However, when the membrane capacitance is in the circuit, the voltage is not reached 
immediately.  Instead, it is approached with the time constant τ which is given by: 
τ=RmCm 
This implies that the charging time constant increases when either the membrane 
capacitance or the resistance increases.  This is particularly important when recording 
from Xenopus oocytes because they are large cells with extensive membrane 
invaginations and have a large charging phase.    
If biological membranes can be represented by a simple RC circuit where (Rm) is 
resistance and (Cm) is the capacitance of a parallel place capacitor, then it can be assumed 
that there is a relationship between the membrane capacitance and the membrane surface 
area.  This relationship was determined by Almers et al., [138], to be 1μF/cm2.  This 
relationship implies that a change in membrane surface area results in a concurrent 
change in membrane capacitance.  To measure these changes, we used modifications of 
the formulas presented previously in conjunction with the modified pClamp5.0 software 
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[136, 149].  In our experiments, the membrane potential was clamped to the reversal 
potential of Cl- (-30mV) followed by a 10mV hyperpolarizing pulse to -40mv (50ms 
duration) to drive chloride out of the oocyte generating a chloride current that can be used 
to calculate membrane capacitance.  The effects of this pulse protocol on the recording of 
Vm and Im can be seen in figure 2-5. 
 
 
 
-30mV
-40mV
 
Figure 2-5: RC parallel circuit response to a voltage step 
Measurement of the membrane voltage (Vm) and membrane current (Im) in response to a 
step change in the command voltage (Vcmd). The current decay constant (τ) is determined 
by the modified pClamp-5 software by fitting the current decay from peak potential 
current (Ipp) to steady state current (Iss) with a single exponential decay curve. 
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Using this protocol, we were able to calculate the Iss or steady state current and the Ipp or 
peak current which was given by: 
Iss=Vcmd/(Rs + Rm) 
 
Ipp=Vcmd/Rs 
 
These equations allowed us to measure the current that was induced by the change in 
voltage, but for us to determine membrane capacitance; we had to calculate the time 
constant of the decay (τ) of the current from the Ipp to the Iss.  This was accomplished by 
the modified pClamp-5 software, which fit this current decay with a single exponential 
decay constant.  When we obtained the decay constant we were then able to calculate the 
membrane capacitance which was given by: 
τ=[(Rm*Rs)/(Rm + Rs)]Cm 
All of the data points necessary to determine membrane capacitance were calculated 
online using the modified pClamp-5 software.   
 The Axon Instruments pClamp-5 program was modified to generate a brief 
command voltage pulse and acquire the resulting membrane potential (Vm) and 
membrane current (Im).  The algorithms used to fit the current decay curve and calculate 
Rm, Rs and Cm were developed by Dr. Akira Takahashi and Dr. Juanjuan Qi in our 
laboratory.  To measure Cm oocytes were voltage clamped at -30mv and the pClamp5 
software generated a 10mV hyperpolarizing voltage pulse to -40 mV with a duration of 
50ms was applied to the oocyte.  During the pulse we sampled current 10ms before the 
end of the pulse at a sampling rate of 170kHz (maximum sampling rate of our digitizer), 
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allowing for the collection of 1700 data points.  To compensate for the possible 
contribution of the pipette glass to the measured Cm, the first 20 points of the collected 
data were discarded.  Starting at data point 21, the next 250 data points (i.e. points 21-
271) near the peak current (Ipp) were fit with a first order exponential decay function.  
The Iss was calculated by averaging the three measurements taken at points 1660, 1680 
and 1700 from the 1700 point data array.  Figure 3-1 A&B shows the curve fitting 
obtained by this method before and after a large change in membrane current is induced 
in oocytes expressing WT-CFTR.   
Validation of this method was performed using a three-fold approach.  The first 
method was the use of model cells which were designed to mimic an oocyte membrane 
expressing WT-CFTR under basal and stimulated conditions.  During these experiments 
Qi & Takahashi found that when measuring the stimulated Cm, there was an 11% 
underestimation of Cm (observed Cm of 330nf vs. 370nF measured Cm).  This was 
explained by the marked value of the capacitor used in the model circuit possibly not 
actually being 370nF.  We also tested our system using the MEO-2U oocyte model cell 
(Molecular Devices, CA).  In these experiments our program measured an average Cm of 
210±1.7nF (n=9).  Compared to the model cell Cm of 220 nF, our measured value 
corresponded to a 5% underestimation of membrane capacitance by our system.   
 In addition to using model circuits, the effect of stimulation of Ca2+ activated Cl- 
currents was measured and showed that increasing the activity of endogenous Cl- 
conductance did not have an effect on the measured membrane capacitance [149].  
Furthermore, the injection of the GABA-C receptor into Xenopus oocytes and the 
subsequent stimulation of GABA-gated Cl- currents did not result in a measured increase 
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in membrane capacitance.  In light of these control experiments, it was clear that changes 
in membrane capacitance measured by the modified pClamp 5.0 software were not 
correlated with increases in membrane conductance.   
2.8 WESTERN BLOT ANALYSIS: 
Western blotting of Xenopus oocyte extracts was performed as described [150].  
Briefly, oocytes were homogenized in 15 mM Tris, pH 6.8 (20 μL buffer/oocyte).  An 
equal volume of 1,1,2-tricloro-trifluorethane (Freon) was added and the oocytes spun for 
10 min. at maximum speed (13,000xg) in a bench top centrifuge.  The upper phase was 
recovered and the remainder treated again with Freon.  Proteins from the upper fraction 
were precipitated with ice-cold methanol and chloroform.  Sample buffer was added, the 
proteins separated by SDS-PAGE, and transferred to Immobilion™-P.  Blots were 
probed with R domain specific α-hCFTR mouse monoclonal IgG1 (1:1000) from R&D 
systems (Minneapolis) or the mouse monoclonal antibody (1:2500) whose epitope lies at 
the CFTR C-terminus (clone 24-1), which was purified from hybridoma supernatant (HB-
11947; ATCC) by Mark Silvis in the lab.  The secondary antibody was donkey α-mouse-
HRP (horse radish peroxidase) from Amersham (1:5000).   
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2.9 STATISTICS & CALCULATIONS 
All data are presented as mean ± S.E.M. where N indicates the number of 
experiments and n is the total number of oocytes studied.  Statistical analysis was 
performed using the Student’s unpaired t test.  A value of p ≤ 0.05 is considered 
statistically significant and shown by an (*) in graphs.  All experiments were performed 
on oocytes harvested from at least three Xenopus laevis to judge reproducibility.  The 
functional half-life of different CFTR constructs was determined by fitting current decay 
curves obtained in the presence of brefeldin A with the two-parameter, single exponential 
decay regression function of SigmaPlot 2001 (SPSS, Chicago, IL).  
We calculated the number of vesicles (Nv) inserted into the plasma membrane in response 
to cAMP/PKA stimulation as described by Bertrand et al. [4], using the equation 
Nv=ΔCm/Cs.4πrG2 
where ΔCm is the measured increase in membrane capacitance, Cs is the specific 
capacitance of a biological membrane (1μF/cm2) and rG is the radius of a spherical 
vesicle, assumed to be 100 nm for this purpose.  
To calculate the number of channels we used the formula: 
Nc=Im/(PoγΔV) 
Where Im is the measured membrane current, Po is the open probability of a CFTR 
channel (0.4), γ is the single channel conductance of a CFTR channel (8pS) and ΔV is 
Vm-VR or membrane potential minus reversal potential.  
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3.0  RESULTS: 
3.1 β-AGONIST INDUCED CURRENT AND CAPACITANCE RESPONSES. 
Representative Im and Cm responses from oocytes expressing WT CFTR are 
illustrated in Figs. 3-1 A&B, and mean data for basal and peak stimulation values from 
15 recordings are summarized in Fig. 3-1C.  In prior experiments of this type, stimulation 
was produced by addition of forskolin plus IBMX [136, 137].  In this study, co-
expression of the β2-adrenergic receptor allowed cAMP/PKA stimulation by addition of 
isoproterenol (10 µM) as employed in previous studies [151, 152].   Stimulation with 
isoproterenol obviated the increase chloride conduction without affecting intracellular 
cAMP that has been reported with various xanthine derivatives such as IBMX [153]. 
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Figure 3-1: Stimulation increases Im and Cm in Xenopus oocytes expressing WT-CFTR. 
Im (A) and Cm (B) recordings from a WT CFTR expressing oocyte during stimulation by bath 
addition of isoproterenol (10 μM), horizontal line.  Vm was held at -30 mV and Im obtained during 
a 10 ms pulse to -60 mV.  Cm was calculated from currents recorded during a 20 mV 
hyperpolarizing voltage pulse, and the inserts (a & b) of panel A provide current recordings 
obtained from pulses before and after isoproterenol stimulation at the times indicated.  The red 
line shows the fit of the current transient used to obtain Cm as described in Experimental 
Procedures where Iss is steady state current and Ipp is the peak point of the current.  Each oocyte 
was injected with 1 ng WT CFTR plus 1 ng β2-adrenergic receptor cRNAs in 50 nl water.  C) 
Average basal and stimulated Im and Cm values are from β2-adrenergic receptor injected oocytes 
[N=3; n=10] or oocytes expressing WT CFTR [N=4; n=15].  A value of p < 0.05 is considered 
statistically significant and shown by an (*) in all experiments. 
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  Prior to stimulation, basal Cl current was 0.10 ± 0.01 μA, and isoproterenol 
produced a current increase (ΔIm) that averaged 2.5 ± 0.13 μA.  This current stimulation 
was paralleled by a 24% increase in membrane capacitance, ΔCm = 46 ± 9.4 nF, from 
192± 8.8 to 238 ± 10.4 nF.  These changes in Im and Cm are CFTR dependent; they are 
not observed in oocytes lacking exogenous CFTR expression (fig. 3-1C).  The 
magnitudes of these responses are consistent with previously published data obtained 
using forskolin plus IBMX as the cAMP/PKA agonists [4, 135, 136].  The observed 
increases in membrane capacitance have been linked to the augmented delivery of CFTR 
to the plasma membrane, detected in prior studies by immunofluorescence labeling of 
CFTR bearing a flag epitope in its fourth extracellular loop [137].  Based on the 
relationship between biological membrane capacitance and surface area (1μF/cm2) and 
using the equations in section 2.9, the corresponding increase in plasma membrane area 
predicted by this capacitance change corresponds to the net fusion of 3.6x107 vesicles of 
100 nm diameter with the plasma membrane.  From the measured ΔIm, the single channel 
current of CFTR at the holding voltage (based on CFTR’s single channel conductance of 
8 pS), and a Po of 0.4, we predict that a number of channels equivalent to the calculated 
number of vesicles contributed to the measured current. However, given the limitations of 
our assumptions, the contribution of membrane resident CFTR channels to the measured 
membrane current cannot be eliminated. Therefore, within the limitations of these 
assumptions, our data suggest that a large portion of the cAMP/PKA stimulated chloride 
current is the result of CFTR trafficking to the cell surface.  
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3.2 STIMULATION INCREASES THE CELL SURFACE EXPRESSION OF 
EXTOPE (EXT) CFTR.  
 Next, we determined cell surface CFTR expression using a different epitope-
tagged CFTR from Peters et al., [137] construct and examined the response to β-agonist 
stimulation.  EXT-CFTR contains a hemagluttinin (HA) tag in an expanded second 
extracellular loop of CFTR [148].  It was kindly provided by Dr. John R. Riordan (UNC-
CH) and sub-cloned into pCDNA3.1-, the construct employed to generate other cRNAs.  
Functional expression of EXT-CFTR exhibited behavior similar to WT CFTR, but 
required ~10-fold more CFTR cRNA (10 ng/oocyte) to obtain quantitatively similar 
stimulated current levels.  As for WT CFTR, basal Cl- currents were low, and addition of 
isoproterenol increased Im and Cm (ΔIm = 1.9 ± 0.21 μA , ΔCm = 26 ± 4.1 nF) (Fig. 3-2 A).  
These values were similar to those obtained from injection of 1 ng WT CFTR (Fig. 3-1).  
The reduced expression efficiency of EXT-CFTR could reflect less effective processing 
of the protein within the ER.   
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Figure 3-2: Current, capacitance and cell surface expression of EXT-CFTR are increased by 
cAMP/PKA stimulation 
A) Im and Cm were obtained from Xenopus oocytes injected with 10 ng EXT-CFTR and 1ng β2-
AR cRNA 3 days prior to measurements [N=4; n=17].  Mean luminometry values from oocytes 
(B) or HEK 293 cells (C) expressing EXT-CFTR (10ng cRNA or 4 μg cDNA/35 mm plates, 
respectively).  Values were background subtracted and normalized to mean values obtained under 
basal, non-stimulated conditions (oocytes: N=4; n=20; HEK cells: N=5; n=20).  
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 We next used the EXT-CFTR construct to evaluate the influence of cAMP/PKA 
stimulation on its surface expression by enzyme linked immuno-labeling and 
luminometry, as described in Experimental Procedures.  Similar experiments were 
performed in both oocytes and HEK 293 cells.  The measurements employed 
modifications of the protocols described by Devor et al. and Jan et al. [154, 155] in 
which cells or oocytes were incubated with primary α-HA followed by an α-mouse-
biotin conjugated secondary, and finally with a streptavidin-HRP conjugated tertiary 
antibody.  As shown in Figs. 3-2 B&C, cAMP/PKA stimulation produced significant, 6- 
and 2-fold increases in cell surface EXT-CFTR detection of oocytes and HEK cells, 
respectively.  Taken together with the agonist-dependent increases in Cm, the β-agonist 
induced surface labeling of EXT-CFTR supports the concept that cAMP/PKA stimulation 
increases CFTR density in the plasma membrane via fusion of CFTR containing vesicles 
that are derived from intracellular compartments.  The response in oocytes was more 
robust than that found in HEK cells.  In relation to prior studies [137], these data also 
indicate that this response does not depend on the position of the epitope tag in CFTR 
since both studies reported a stimulation dependent increase in membrane expression 
with epitope tags at different positions on the channel.   
3.3 STIMULATION OF CFTR REDUCES ITS FUNCTIONAL HALF-LIFE 
 Next, we evaluated the hypothesis that the stimulation of CFTR trafficking may 
alter its functional stability in the plasma membrane.  Results consistent with this 
interpretation have emerged from prior studies of other transporters/channels whose 
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trafficking is subject to acute regulation [156, 157].  To examine this possibility, we 
determined the decay of CFTR currents following the inhibition of anterograde 
membrane traffic with brefeldin A (BFA), both before and during isoproterenol 
stimulation of channel trafficking to the cell surface.  This method is used commonly to 
examine the functional half-life of channels in this expression system [158].   
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 Figure 3-3 The functional half-life of CFTR is reduced during cAMP/PKA stimulation. 
Current decay curves were produced by continuous incubation of oocytes expressing WT-CFTR 
(1ng) and β2-AR (1ng) with brefeldin A (10 μM).  The data were fit with a single exponential 
function using SigmaPlot (Systat Software,CA).  A) Oocytes were stimulated continuously with 
10 μM isoproterenol and currents were recorded at 0, 2, 4, 8 and 24 hrs [N=5; n=20, each data 
point].  B) Currents were recorded from oocytes after (0, 1, 2, 4, 8, 24) hours of treatment with 
10μM BFA.  Current measurements were obtained at maximal stimulation following 
isoproterenol stimulation at the indicated times by ( ) [N=4; n=16].   
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As shown in Fig. 3-3, oocytes expressing WT CFTR were bathed continuously in 10 μM 
BFA.  One group was exposed to continuous stimulation, with agonist present throughout the 
indicated time-course (Fig. 3-3A).  The other group was stimulated periodically at the indicated 
times (arrowheads, Fig. 3-3B).  When the cells were continuously exposed to agonist, their 
currents declined more rapidly (t1/2 = 8.5hrs) than those stimulated only at the indicated 
measurement times (t1/2 = 29hrs).  The more rapid decline in current with constant stimulation 
was not due to β2-AR desensitization, since similar data were obtained also in response to 
stimulation by forskolin plus IBMX (t1/2 = 6.4 hrs for constant stimulation and t1/2 = 24.71hrs for 
periodic stimulation).  The decrease in functional channel half-life observed with constant 
stimulation is consistent with the hypothesis that CFTR is relatively stable when it resides within 
intracellular compartments prior to stimulation, but that in response to agonist, the channel 
traffics more rapidly through plasma membrane-endosomal pathways, resulting in reduced 
functional stability.  Similar findings have been obtained for GLUT4 and ENaC.  In response to 
insulin, the half-life of GLUT4 was reduced from 50 to 15 hrs [157], while that of ENaC was 
decreased from 20 to 5 hrs in response to cAMP stimulation [156].  Similarly, the functional 
half-life of CFTR was reduced by a factor of ~3.5 during continuous cAMP/PKA stimulation. 
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3.4 R DOMAINLESS CFTR LACKS MEMBRANE CURRENT AND CAPACITANCE 
STIMULATION 
Prior studies by Csanady et al., [111] have shown that regulated CFTR channel 
activity could be expressed from half-channels encoded by two cRNA constructs (so-
called split CFTR).  In addition to the ability of the split CFTR constructs to function 
similar to WT-CFTR, the ease in generating deletions using the split constructs also made 
them an attractive alternative to full-length WT-CFTR.  In preparation for the expression 
of split CFTR lacking the R domain, we first examined the agonist-evoked changes in 
current and capacitance of split CFTR expressed from two co-injected cRNAs.  Our first 
series of split CFTR constructs contained the R-domain, which when co-injected into 
oocytes contained a complete CFTR cRNA which was “split” into two constructs.  The R 
domain containing constructs encoded amino acids 1-834 or 635-1480, and they were co-
expressed with the remaining CFTR sequence from a separate co-injected cRNA, i.e. 1-
834 + 835-1480 or 1-634 + 635-1480.   Figure 3- 4A shows that these split CFTRs 
behaved indistinguishably from the intact protein (compare with Fig. 3-1), having low 
basal currents and substantial increases in both Im and Cm during cAMP/PKA stimulation.  
The current findings replicate those of Csanady et al., [111], but the increased Cm values 
show also that the regulated CFTR trafficking property of the intact protein is retained.  
In addition, as illustrated in Fig. 3-4B, the functional turnover of the split CFTR (1-834 + 
835-1480) was similar to that of WT CFTR under constant stimulation conditions.  Thus, 
the regulated gating and trafficking properties of WT CFTR are retained in these split 
constructs, permitting their further modification.   
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Figure 3-4: The functional properties of split CFTR constructs resemble those of WT CFTR. 
A) Oocytes were co-injected with 0.5 ng of the CFTR half-channel cRNAs (1-834 + 835-
1480, [N=4; n=16] or 1-634 + 635-1480, [N=3; n=10] and 1 ng β2-AR, and Im and Cm 
were recorded in response to 10 μM isoproterenol, as in Fig. 1.  B) Oocytes co-injected 
with split CFTR (1-834 + 835-1480 and β2-AR, as in A) were bathed continuously in 10 
μM BFA and 10 μM isoproterenol and Im measured at the indicated times [N=4; n=20].   
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The expression of split CFTR lacking the R domain (1-634 + 835-1480; termed 
ΔR-N/C) resulted in a high basal current that was not further augmented by cAMP 
stimulation, as found in previous studies of this construct [111].  Figure 3-5 A-C show 
representative current and capacitance recordings and the summary data from oocytes 
expressing ΔR-N/C CFTR.  The spontaneous basal currents produced by omission of the 
R domain (1.9 ± 0.18 μF) were similar to the stimulated currents of WT CFTR (2.5 ± 
0.13 µA) and EXT-CFTR (1.9 ± 0.21μΑ).  In addition to the absence of an isoproterenol-
induced current, stimulation of oocytes expressing ΔR-N/C CFTR did not elicit an 
increase in Cm (Fig. 3-5 B&C).  Thus, in addition to forming a constitutively active 
channel, ΔR-N/C CFTR does not undergo a regulated trafficking response; rather, CFTR 
lacking its R domain is trafficked constitutively to the plasma membrane.  These findings 
suggest that the presence of a non-phosphorylated R domain is necessary for CFTR to 
enter a regulated intracellular compartment from which it is trafficked to the plasma 
membrane in response R domain phosphorylation.   
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 Figure 3-5: CFTR lacking the R domain does not exhibit regulated current or capacitance responses. 
A&B) Time-courses of Im and Cm in an oocyte injected with ΔR-N/C cRNAs (0.5ng each, 
1-634 + 835-1480) plus 1ng β2-AR.  Horizontal bar indicates addition of 10 μM 
isoproterenol.  C) Summary Im and Cm data for ΔR-N/C expressing oocytes [N=6; n=29].  
D) Following addition of 10 μM brefeldin A, decay of spontaneous ΔR-N/C CFTR Im 
yields a functional t1/2 of ~30 min; expression conditions as in A [N=3; n=8]. 
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The functional half-life of WT CFTR was reduced by its continuous stimulation 
(Fig. 3-3), which was attributed to its mobilization from a stable intracellular 
compartment.  Accordingly, it was of interest to examine the turnover of ΔR-N/C, since 
this combination of half-channels behaves as if it were cAMP/PKA stimulated.  Oocytes 
expressing ΔR-N/C CFTR were incubated with 10 μM BFA.  Since preliminary 
experiments indicated that the current decline following BFA addition was rapid, the 
decay of the spontaneous currents of ΔR-N/C CFTR was measured during continuous 
recordings.  As shown in Fig. 3-5D, the half-life of the ΔR-N/C construct was very brief, 
at 0.5 ± 0.1 hrs.  Thus, the R domainless CFTR exhibited the least functional stability of 
any CFTR construct we examined, and this property likely contributes to its somewhat 
lower overall current level relative to WT CFTR.  Data obtained with the split CFTR that 
retains the R domain (Fig. 3-4B) suggests that the rapid turnover of ΔR-N/C is not due to 
the use of a split CFTR construct.  The short half-life of ΔR-N/C CFTR suggests that 
structures within the R domain contribute to the stability of CFTR at the plasma 
membrane 
In prior studies, we found that the ΔCm response of WT CFTR reached a plateau 
as CFTR expression and the corresponding ΔΙm was increased, which was done by 
augmenting cRNA dose [136].  To verify that the lack of a ΔCm for ΔR-N/C was not 
compromised in some way by assessing only a restricted expression level, we determined 
its ΔCm-ΔIm relation over a range of cRNA expression, in comparison with WT CFTR.  
As figure 3-6 shows, the ΔCm response of ΔR-N/C to stimulation was minimal over a 
broad range of expression.  In addition, these data show that the expression level of WT 
 79 
CFTR used in these studies (yielding ~2 μA current) was within the range where ΔCm is 
directly proportional to the ΔIm response. 
 
 
 
 
Figure 3-6: Varying amount of cRNA injected does not affect the Cm response of R-domain deletion  
ΔCm-ΔIm relations for WT, ΔR-N/C and ΔNEG2 CFTRs.  Isoproterenol- induced changes in 
current and capacitance were varied by injecting different amounts of cRNAs (ng): WT CFTR 
and ΔR-N/C, 0.5, 1, 2.5; ΔNEG2, 2.5, 3.5, 7, 15; N=2, n=8.    
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3.5 INDIVIDUAL HALF CHANNEL CONSTRUCTS DO NOT FORM A 
FUNCTIONAL CHANNEL. 
Next, we addressed the possibility that the properties of ΔR-N/C might have 
arisen from the function of individual half-channels rather than association of the channel 
halves.  Previous studies by Devidas and co-workers [159] suggested that CFTR 
constructs comprised of TM1 + NBD1 or TM2 + NBD2 formed constitutively active 
channels when expressed in Xenopus oocytes.  In view of the high level of cRNA used in 
those studies (50 ng/oocyte), we asked whether the half-channel constructs would 
generate significant currents at the lower cRNA levels employed here (i.e. 0.5 ng).  
Expression was allowed to proceed for the same time period (3 days).  The basal and 
stimulated currents obtained from these cRNAs, and others used in the present studies, 
are provided in Table 3-1.  Relative to WT CFTR, split CFTR or ΔR-N/C, the individual 
half channels did not produce significant currents.  Therefore, the currents obtained from 
split and ΔR-N/C CFTRs derive from the assembly of half-channels. 
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Table 3-1 Basal and stimulated currents recorded from Xenopus oocytes expressing WT CFTR and 
individual half-channel cRNAs.    
cRNA Basal Im (μA) Stimulated Im (μA) μg cRNA n 
WT-CFTR -0.10±0.01 -2.7±0.14 1 15 
1-634 -0.10±0.04 -0.02±0.002 0.5 8 
835-1480 -0.09±0.02 -0.04±0.01 0.5 10 
1-834 -0.16±0.02 -0.02±0.03 0.5 8 
635-1480 -0.20±0.04 -0.20±0.02 0.5 9 
 
Column one shows the cRNA construct injected into each oocyte.  Columns 2 and 3 show 
the average basal and stimulated Im recorded with 2EVC. Column 4 & 5 list the amount 
of cRNA injected and the number of 2EVC recordings for each construct.   
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3.6 EXPRESSION OF THE R DOMAIN DID NOT RESTORE REGULATION TO 
ΔR-N/C 
Since a regulated CFTR trafficking response required the R domain, we asked 
whether its co-expression with ΔR-N/C would restore a stimulation-dependent current 
and capacitance responses.  This outcome would facilitate studies designed to identify a 
region within the R domain that contributes to the ΔCm.  In BHK cells, Chappe et al. 
[126] found that co-expression of the R domain with CFTR half-channels encoded by a 
bisistronic construct partially reduced the spontaneous anion efflux and channel activity 
of split ΔR expressing cells and also partially restored their cAMP/PKA responsiveness.  
However, as seen in Fig. 3-7A, the co-expression of R domain cRNA with ΔR-N/C failed 
to significantly reduce its spontaneous current or restore cAMP/PKA regulation, despite a 
five-fold excess of R domain cRNA.  To ensure that the R domain polypeptide was 
expressed, western blot analysis was performed using lysates from oocytes co-injected 
with R domain and ΔR-N/C cRNAs, or with ΔR-N/C alone.  The blot of Fig. 3-7B shows 
that the lack of recovery of regulated current was not due to a lack of R domain 
expression, but likely results from an inability of the R domain to properly assemble with 
the half-channels. 
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Figure 3-7: Expression of the R domain does not induce regulated behavior of ΔR-N/C 
cRNA expression conditions: 0.5ng each ΔR-N/C cRNAs, with or without 5 ng R 
domain, plus 1ng β2-AR cRNA. A) Mean basal and stimulated Im and Cm values ΔR-N/C 
[N=3; n=14] and ΔR-N/C + R-domain, [N=3; n=17].  The source of the difference in 
mean Cm values of these groups is not known; however, these values are within the range 
observed and variation does arise from oocyte size and membrane folding [135].  B) 
Immunoblot of lysates from oocytes expressing ΔR-N/C or ΔR-N/C + R-domain; 
expression conditions as in A.  Membranes were probed with R domain specific anti-
CFTR mAb (1:1000); see Experimental Procedures for protocol. 
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3.7 THE NEG2 REGION IS REQUIRED FOR CAMP/PKA-DEPENDENT CFTR 
TRAFFICKING   
 The co-expression of R domain constructs with ΔR-N/C did not allow us to 
narrow the R region involved in regulated CFTR trafficking.  Therefore, we progressively 
deleted amino acid segments from the C-terminus of the 1-834 construct and co-
expressed these with the complementary C-terminal construct, 835-1480.  Of those 
examined (Table 3-2), only the split CFTR combination 1-784 + 835-1480 generated 
significant currents above baseline levels.   
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Table 3-2: R-domain deletion constructs examined and results of cAMP/PKA stimulation on Im 
 
R-Domain deletion 
cRNAs Basal Im (μA) Stimulated Im (μA) ng cRNA 
n 
1-634 + 835-1480 -1.9±0.17 -2.1±0.18 0.5 29 
1-653 + 835-1480 -0.07±0.04 -0.11±0.02 5 7 
1-673 + 835-1480 -0.17±0.01 -0.15±0.04 5 8 
1-693 + 835-1480 -0.11±0.03 -0.10±0.02 5 7 
1-713 + 835-1480 -0.09±0.06 -0.11±0.04 5 10 
1-733 + 835-1480 -0.12±0.05 -0.11±0.01 5 8 
1-753 + 835-1480 -0.06±0.02 -0.08±0.05 5 11 
1-773 + 835-1480 -0.12±0.01 -0.11±0.03 5 7 
1-784 + 835-1480 -0.33±0.02 -1.5±0.30* 3.5 11 
1-816 + 839-1480 -0.84±0.25 -1.9±0.51* 3.5 14 
 
Graphical representation of split CFTR constructs used. Table lists the construct(s) 
injected and the average basal and stimulated Im recorded with 2EVC.  The amount of 
cRNA of each half channel construct injected and the number of experiments performed 
with each construct is shown in columns 4 and 5. (*) indicates significant difference 
between basal and stimulated data (p<0.05). 
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As illustrated in Fig. 3-8 A&B, this 51 amino acid deletion, which retained 12 of 19 PKA 
phosphorylation sites, produced somewhat elevated basal currents while remaining 
responsive to cAMP/PKA stimulation unlike ΔR-N/C [113].  However, 1-784 + 835-
1480 CFTR showed no stimulation-dependent increase in membrane capacitance (Fig. 3-
8C).  Therefore, this combination of half-channels structurally dissociates the ΔCm and 
ΔIm responses of CFTR to cAMP/PKA stimulation.  In addition, this data verifies that the 
measured ΔCm is not a technical artifact that is linked in some way to the ΔIm.  The 
absent Cm response suggests that 1-784 + 835-1480 CFTR lacks regulated recruitment to 
the plasma membrane and indicates that this region of the R domain accounts for the 
similar properties of ΔR-N/C. 
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 Figure 3-8: Partial R domain deletions mimic the absence of a trafficking response in ΔR-N/C. 
A&B) Im and Cm recordings of split CFTR (1-784 + 835-1480) co-expressed with β2-AR; 
all cRNAs 1 ng/oocyte.  Horizontal bar indicates the addition of 10 µM isoproterenol. C) 
Summary data for 1-784 + 835-1480 CFTR [N=3; n=11]. D) Summary data for split 
ΔNEG2 (1-816 + 839-1480) injected oocytes; cRNAs 1 ng/oocyte [N=4; n=16]. 
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3.8 CFTR TRAFFICKING DEPENDS ON THE NEG2 REGION AND ITS HELICAL 
PROPERTIES.   
 Lying in the 784-835 region of the R domain is a stretch of negatively charged 
amino acids (aa 817-838) designated by Ma and coworkers as NEG2 [5, 6].  In their prior 
studies, this region of the R domain influenced CFTR gating.  Its 22 amino acids have a 
net charge of -9, and the peptide exhibits significant α-helical content, assessed by CD 
spectroscopy [6].  On this basis, we developed split CFTR constructs lacking the NEG2 
region (1-816 + 839-1480), and designated their co-expression as ΔNEG2 CFTR.  As 
shown in Fig. 3-8D, their behavior was qualitatively similar to the larger deletion, 1-784 
+ 835-1480.  As shown in Table 3-2, the basal currents of ΔNEG2 were more elevated, 
but the stimulated current levels were similar.  As found for ΔR-N/C and 1-784 + 835-
1480 CFTR, this channel did not display the cAMP/PKA-dependent stimulation of Cm 
that is characteristic of WT CFTR.   
 To determine whether the NEG2 peptide itself could influence the regulated 
trafficking of CFTR, we injected the peptide (817-838) into oocytes expressing ΔNEG2. 
Based on prior experience with similar protocols [160], the 20 min period prior to 
initiation of stimulation should be more than sufficient for peptide diffusion within the 
oocyte.  Figure 3-9A provides the mean data from this set of experiments.   
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 Figure 3-9: Peptide injection restores regulated trafficking to ΔNEG2 
A) Summary data for ΔNEG2 expressing oocytes injected with 23 nl of 50 mM NEG2 peptide 
(~1 nmol) prior to Im and Cm recordings [N=4; n=14]; cRNA 7 ng/oocyte).  B) Oocytes co-
injected with split ΔNEG2 and β2-AR cRNAs were bathed continuously in 10 μM BFA and Im 
measured at the indicated times [N=3; n=18].  C) Summary data for changes in Cm (%) evoked by 
10 µM isoproterenol following injection of the indicated peptide into oocytes expressing split 
ΔNEG2 CFTR (as in A).  Sequences of peptides:  NEG2, GLEISEEINEEDLKECFFDDME; 
sNEG2, LIKEFSEEDGECLMIDEDENEF; hNEG2, GLEISEQINQQNLKQSFFNDME  See [6] 
for discussion of peptide structures as determined by circular dichroism. sNEG2, [N=3; n=12]; 
hNEG2, [N=4; n=16].  D)  3D rendering of WT and mutant NEG2 peptides generated using the 
Kinemage, Next Generation (KiNG) display software available from 
(http://kinemage.biochem.duke.edu/software/king.php) with negatively charged amino acids 
shown in red 
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 Following NEG2 peptide injection, the basal and stimulated currents were not 
markedly different from those of ΔNEG2 alone; however, a significant ΔCm (29.2±2.03 
nF) response to cAMP/PKA stimulation was now observed.  Within this time frame, 
peptide injection was unable to reproduce the full magnitude of the ΔCm response of WT 
CFTR, and this may result from incomplete structural complementation by the peptide or 
to the need for additional time for the formation of a regulated trafficking compartment 
within the cell.  Despite this quantitative difference, the data is consistent with the view 
that the NEG2 region is required for regulated CFTR trafficking.  
 To further assess the properties of NEG2, as done originally by Ma et al. [6], two 
additional peptides were synthesized that eliminated the helical content of NEG2 or 
reduced its net negative charge (see fig. 3-9D for graphic).  One peptide (sNEG2) 
consists of a scrambled NEG2 sequence that disrupts the helical structure but preserves 
the negative charge; the other peptide, (hNEG2) has reduced negative charge (-9 to -3) 
but retains helical structure [6].  The remaining negative charge of hNEG2 was necessary 
to maintain peptide solubility [6].   
 As shown in Fig. 3-9C, we determined the influence on agonist-dependent Im and 
Cm of introducing these peptides into oocytes expressing ΔNEG2 CFTR.  The sNEG2 
peptide did not restore the agonist stimulated increase in Cm, while hNEG2 peptide 
injection reproduced a similar ΔCm response as that observed with NEG2 peptide 
injection.  Elimination of the agonist induced ΔCm with sNEG2 and its preservation with 
hNEG2 suggest that the helical content of NEG2 is a primary requisite for this region to 
support the regulated trafficking of CFTR.   
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Figure 3-10: hNEG2-CFTR retains regulated trafficking properties. 
A) Im and Cm summary data for hNEG2-CFTR [N=3; n=13] & sNEG2-CFTR [N=3; 
n=10].  B) Western blot of HEK 293 cells transfected with WT CFTR, hNEG2-CFTR or 
sNEG2-CFTR.  Cells were transfected with 4 µg cDNA, each construct; after 24 hrs, 
cells were harvested and subjected to immunoblot using mAb directed against the CFTR 
C-terminus (1:2500).  Typical of results from 3 experiments. 
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  These findings were further explored by incorporating the sNEG and hNEG 
sequences into full-length CFTR.  PCR-based mutagenesis (see Methods) was employed 
to generate mutations within the NEG2 region.  The resulting constructs were designated 
sNEG2-CFTR or hNEG2-CFTR.  Similar to findings with hNEG2 peptide injection, 
hNEG2-CFTR yielded agonist induced increases in both Im and Cm, as illustrated in Fig. 
3-10A.  In addition, the basal current of hNEG2-CFTR was similar to that observed for 
WT CFTR expression.   In contrast, attempts to express sNEG2-CFTR did not yield 
currents higher than those observed in non-injected oocytes.  The explanation for this 
negative finding was provided by western blots of HEK 293 cells transfected with WT 
CFTR, hNEG2-CFTR or sNEG2-CFTR plasmids (Fig. 3-10B): WT and hNEG2-CFTR 
were expressed at similar levels, whereas the sNEG2-CFTR construct did not produce a 
detectable product.  These data, in conjunction with the peptide co-injection experiments, 
strongly suggest that the NEG2 region is required for regulated CFTR trafficking and that 
its helical content is an important structural feature necessary for the response. 
3.9 SYNTAXIN 1A INHIBITION IS ELIMINATED IN ΔR-N/C AND ΔNEG2 CFTR  
 Prior studies have indicated that a physical interaction of syntaxin 1A (S1A) with 
the CFTR N-terminus reduces the regulated currents of CFTR expressed in oocytes [161, 
162].  Other work [137] attributed the action of co-expressed S1A to an inhibition of 
CFTR trafficking, detected using membrane capacitance measurements and external 
epitope tag labeling, similar to the present studies.  
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Figure 3-11: Deletion of NEG2 region eliminates the effect of syntaxin 1A on CFTR-mediated ΔIm 
and ΔCm. 
cRNA injections: WT-CFTR (1ng), ΔR-N/C (1ng total) or ΔNEG2 (7.5ng) with or 
without S1A (10ng), as indicated, plus β2-AR (1ng); stimulation with 10μM 
isoproterenol. (*) significant difference between basal and stimulated conditions 
(p<0.05); (++) indicates a significant difference with S1A co-expression (p<0.05). N=2; 
n=9, all groups. 
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 Given the requirement for the R domain and specifically the NEG2 region in 
regulated CFTR trafficking, we examined the influence of co-expressed S1A on the 
properties of ΔR-N/C and ΔNEG2 CFTR.  As illustrated in Fig. 11, the action of S1A on 
WT CFTR recapitulated the results of prior studies in which its co-expression reduced 
cAMP/PKA stimulated CFTR currents and eliminated the agonist-evoked ΔCm.  
However, these inhibitory effects were absent when S1A was co-expressed with ΔR-N/C 
or ΔNEG2 CFTR.  The elevated basal currents of ΔR-N/C and ΔNEG2 CFTR were not 
altered by S1A, nor was the current response of ΔNEG2 CFTR to stimulation.  Thus, 
these R domain deletion mutants, which exhibit no ΔCm response to agonist, are also 
unresponsive to S1A inhibition.  The functional interaction between this SNARE protein 
and CFTR, like the regulated trafficking response of CFTR, requires the NEG2 region 
.   
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4.0   DISCUSSION:  
  
 
The primary goal in this work was to determine whether a structural feature, within 
CFTR itself, contributes to its cAMP/PKA regulated trafficking at the plasma membrane.  Our 
rationale was that the identification of a CFTR component that is required for the trafficking 
response could lead ultimately to elucidation of the trafficking mechanism, and potentially 
provide targets for modulating the apical membrane density of CFTR mutants (see Introduction).   
Xenopus oocytes display a robust CFTR trafficking phenotype, and calculations based on the 
present data suggest that the recruitment of CFTR from intracellular compartments accounts for 
most of the current response in this system.  Oocytes exhibit agonist evoked, CFTR-dependent 
increases in membrane capacitance and in plasma membrane CFTR labeling using an expression 
construct containing a flag epitope tag in CFTR’s fourth extracellular loop, ECL4 [137]  This 
approach has been used by others to measure the cell surface expression of ENaC [163, 164] and 
other channels [165].  In the present studies, we confirmed this finding using a CFTR construct 
bearing an HA tag in ECL2, so-called EXT-CFTR.  Gentzsch et al. [148] developed EXT-CFTR 
and characterized its regulated function using halide efflux measurements.  As for WT CFTR, we 
observed increases in Im and Cm from EXT-CFTR upon cAMP/PKA stimulation.  The 
current/capacitance responses of WT and EXT-CFTR were similar (57 vs. 67 pA/pF), indicating 
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that its regulated plasma membrane trafficking properties replicate those of WT CFTR and 
CFTR tagged in ECL4.  Thus, the detection of a stimulus-induced increase in plasma membrane 
CFTR is independent on the position or composition of the epitope tag.    
 cAMP/PKA evoked changes in membrane capacitance were used to assess the 
trafficking of CFTR as its structural features were manipulated.  Given that the initiation of both 
gating and trafficking responses require phosphorylation of the CFTR R domain, it was logical to 
begin this process using constructs in which the R domain was deleted.  Csanady et al. [111], 
showed that CFTR’s gating properties were maintained when split CFTR half-channels lacking 
the R domain were co-expressed in Xenopus oocytes, providing the opportunity to examine the 
relation of CFTR trafficking to R domain structure.  As in prior studies [111], we found that split 
CFTR lacking the R domain, ΔR-N/C, exhibited spontaneous currents that were not significantly 
increased by cAMP/PKA stimulation.  In addition, the agonist-induced ΔCm, reflecting the 
regulated trafficking of WT CFTR to the cell surface, was eliminated, identifying the R domain 
as a necessary structural feature in this process.   
R-domainless and ΔNEG2 CFTRs exhibited a reduced functional half-life, resembling that of 
WT CFTR during continuous stimulation by cAMP/PKA.  These findings suggested that under 
non-stimulated conditions, CFTR resides in an intracellular compartment where it is relatively 
stable.  This stability may arise from the kinetics of plasma membrane trafficking steps that 
distribute CFTR predominantly to intracellular compartments in the absence of stimulation.  As 
noted above, similar behavior is observed in response to the acute stimulation of GLUT4 and 
ENaC trafficking.  
To further resolve the R region involved in stabilizing CFTR within the cell, segments of the 
R domain C-terminus were progressively deleted from the half channel construct that included 
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the R domain (e.g. 1-835).  Large R region deletions were problematic, however.  As 
demonstrated previously [166, 167], functional CFTR expression was lost when regions at the N-
terminus of the R domain were eliminated.  Nevertheless, the expression of constructs that 
eliminated smaller C-terminal segments of R revealed that removal of the NEG2 region 
eliminated agonist-stimulated trafficking of CFTR while retaining most of CFTR’s regulated 
conductance function.   
Confirming the importance of this segment, prior injection of NEG2 peptide restored a 
regulated trafficking response to ΔNEG2 CFTR, although the agonist-induced ΔCm was reduced 
by approximately 35% compared to that of WT CFTR.  The functional complementation of 
regulated CFTR trafficking by peptide injection depended on the previously determined helical 
structure of NEG2 [6], as peptide lacking helical content failed to recover agonist-evoked 
capacitance changes, despite the retention of NEG2’s negative charge.  This feature was 
confirmed for full-length CFTR in which the NEG2 region was substituted by the helical 
counterpart, hNEG2.  Nevertheless, hNEG2 retains a net negative charge of -3, which was 
minimally required for peptide solubility [6], and this may contribute to the regulated trafficking 
response observed. 
The relatively short time for recovery of cAMP/PKA regulated trafficking following NEG2 
peptide injection (~30 min between injection and stimulation) suggests that the intracellular 
CFTR trafficking compartment that contributes to the increase in Cm with stimulation can be re-
filled relatively quickly.  Previous studies of CFTR turnover at the cell surface are compatible 
with this short timescale for recovery.  For example, in T84 cells, ~50% of CFTR on cell surface 
was internalized within 15 min [130], and similar CFTR endocytic internalization rates were 
observed in COS-7 cells expressing WT CFTR  [168].  Time courses of CFTR internalization 
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and recycling with similar kinetics were reported recently for polarized human airway cells 
[169].  These findings suggest that CFTR endocytosis and recycling at the plasma membrane 
domain are sufficiently rapid to permit the formation of a trafficking compartment within the 
timeframe of these experiments.   
Evidence for the ability of the NEG2 peptide to functionally associate with NEG2 deleted 
CFTR was provided by Ma and co-workers [6].  They showed that the addition of NEG2 to the 
cytoplasmic surface of WT or ΔNEG2-CFTR in lipid bilayers altered CFTR open probability in a 
biphasic, concentration-dependent manner.  Since low NEG2 concentrations enhanced Po, while 
higher NEG2 concentrations reduced CFTR Po, Ma et al., [6] proposed that the amphipathic 
nature of the NEG2 helix facilitates its interaction with a gating inhibitory site in the non-
phosphorylated channel, stabilizing the closed state, while its interaction with a stimulatory site 
in the phosphorylated channel augments channel opening [6].  Overlaid on this concept, the 
present findings suggest that the NEG2 region interrupts the constitutive trafficking of CFTR to 
the plasma membrane when the channel is not phosphorylated, permitting its entry into a 
kinetically stable intracellular compartment.  Subsequently, R domain phosphorylation would 
suppress these interactions of NEG2, which may include its association with components of the 
trafficking machinery, permitting the progression of phosphorylated CFTR to the surface 
membrane. 
As a prototype for this model, we examined the influence of syntaxin 1A on the behavior of 
ΔR-N/C and ΔNEG2 CFTRs.  The regulation of CFTR by this SNARE protein is complex, 
involving its physical interaction with the CFTR N-terminal tail, which itself influences channel 
open probability [170].  In addition, prior work in oocytes showed that S1A co-expression with 
WT CFTR reduced its regulated trafficking to the cell surface [137], and this action was 
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confirmed here by the inhibition of stimulated WT CFTR current and the block of agonist-
induced ΔCm associated with S1A co-expression (Fig. 11). As previously [137], we attribute this 
effect of S1A to its ability to retain CFTR within intracellular compartment(s), similar in 
principle to the concept that the NEG2 region is required for intracellular stabilization of CFTR 
under basal conditions.  Thus, elimination of the NEG2 region, allows CFTR to traffic 
constitutively to the plasma membrane, and this deletion also obviates the block of CFTR 
progression to the cell surface elicited by S1A expression.  In this light, when CFTR is not 
phosphorylated, NEG2 may interact with a traffic regulatory protein, such as a SNARE protein, 
and that this interaction causes intracellular CFTR retention within non-stimulated cells.  It is 
possible also that this regulatory protein interaction is effected by another part of CFTR with 
which NEG2 associates.  Nevertheless, attempts to further resolve the molecular details are 
outside the scope of the present work.    
In summary, cAMP/PKA stimulation increases cell surface expression of CFTR in addition 
to augmenting CFTR channel gating, and both modes of regulation require the R domain.  Its 
removal permits CFTR gating in the absence of agonist stimulation and also eliminates the 
ability of the channel to enter a regulated trafficking pathway, resulting in the constitutive 
delivery of CFTR to the plasma membrane.  Our findings identify the NEG2 region of the R 
domain, aa 817-838, as the critical structural element of CFTR that is required for its 
phosphorylation-dependent trafficking.  Accordingly, the intracellular retention of CFTR under 
non-phosphorylated conditions may involve interactions of the NEG2 region with proteins that 
mediate regulated membrane trafficking events.  Since NEG2 also influences channel gating [6], 
these findings imply that regulation of the gating and trafficking functions of CFTR are 
structurally linked.  The identification of NEG2 as a required structural component should lead 
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to a better understanding of CFTR trafficking mechanisms, including the associated protein-
protein interactions. 
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APPENDIX: 
In this section, the work presented was not directly part of the thesis project described 
previously.  Instead, the data presented in this section, are collaborations in which several 
investigators contributed to the totality of the work.  
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5.0  SERUM-GLUCOCORTICOID-INDUCED KINASE (SGK-1) 
REGULATION OF CFTR. 
 
 
5.1 INTRODUCTION: 
 
Serum-glucocorticoid-induced kinase (SGK-1) is an inducible Ser/Thr kinase that 
belongs to the family of AGC (PKA/protein kinase G/protein kinase C) kinases.  It was 
originally isolated from a mouse tumor cell line during a differential screening for 
glucocorticoid-induced transcripts [171, 172].  The most understood functions of SGK-1 
are that of a kinase involved in cell survival in various situations as well as its ability to 
regulate multiple membrane, transport and channel proteins [173].  Studies have shown 
that SGK-1 is tightly regulated by numerous signaling molecules through its sub-cellular 
localization, expression levels and its intrinsic kinase activity, thus allowing it to integrate 
numerous signaling pathways [173]. 
To date, two paralogues of SGK-1 have been identified (SGK-2 & SGK-3) which 
share 80% amino acid identity in their catalytic domains with SGK-1 and each other 
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[174-176].  The consensus phosphorylation motifs for SGK-1 require arginines at 
positions 5 and 3 while basic residues C-terminal of S/T are inhibitory with no 
requirement for bulky hydrophobic residues which translates into a consensus site of 
RXRXXS/T for SGK-1 [177-179]. 
5.1.1 Regulation of SGK-1 by phosphorylation. 
 A characteristic of many AGC kinases is the conserved phosphorylation motifs in 
their catalytic domain and the C-terminal region as shown in figure 5-1.  The 
phosphorylation sites located in the catalytic domain are situated in the activation loop 
(A-loop) which was first identified in PKB/Akt (Protein kinase B/Akt) as a target for the 
PI-3K dependent kinase PDK-1 (3-phosphoinositide-dependent protein kinase 1) [180, 
181].  Generally PDK-1 activation involves interaction of PDK-1 and its target with 
phosphoinositides through its pleckstrin homology (PH) domains.  This interaction 
recruits both kinases to the plasma membrane and allows PDK-1 to phosphorylate the 
AGC kinase on the A-loop.  However, SGK-1 does not have a PH domain, instead SGK-
1 is phosphorylated on Ser-422 in the C-terminal hydrophobic (H-motif) by an as yet 
unknown kinase that is PI-3K dependent [179, 182] (figure 5-1).  This indicates that the 
activation of SGK-1 by PDK-1 is independent of phosphoinositides, or the PH-domain in 
PDK-1, which makes activation of SGK-1 much slower that that of PKB/Akt.   
 Other kinases may also activate SGK-1.  For example, PKA may also activate 
SGK-1 via phosphorylation of a consensus sequence surrounding Thr-369 (KKITP).  
However, this site is imperfect and other groups have not been able to detect activation of 
SGK-1 by cAMP under conditions were cAMP was able to phosphorylate the CREB 
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transcription factor [183]. Evidence suggests that various MAP kinases, specifically bone 
marrow kinase (BMK) and p38α, phosphorylate and activate SGK-1.  Both of these 
kinases phosphorylated SGK-1 at a site (ser78) which lies outside of the catalytic domain 
and increase activity independent of the phosphorylation state of Thr256 in the A-loop. 
[184, 185].  Another potential mechanism of SGK-1 activation is through interaction with 
WNK1 (with no lysine kinase 1) [176].  Like activation of SGK-1 by BMK and p38α, the 
mechanism of WNK1 activation is not completely understood.  However, there is some 
evidence that phosphorylation of SGK-1 at Ser-422 in addition to phosphorylation of 
Thr-256 is required [176].   
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 Figure 5-1: Model of human SGK-1 [186] 
Structural representation of serum-glucocorticoid induced kinase (SGK-1).  The drawing 
illustrates that SGK-1 contains two regulatory features: phosphorylation of the activation loop 
and phosphorylation of a hydrophobic motif (blue box), located in the tail region (red box) C-
terminal to the kinase domain. 
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5.1.2 Regulation of SGK-1 by ubiquitylation. 
 Another mode of SGK-1 regulation is mediated by ubiquitylation.  Studies by 
Brickly et al., [187] have shown that the rapid internalization and proteosome 
degradation of SGK-1 requires ubiquitylation [187].  The E3 ubiquitin ligase, NEDD4-2 
(neuronal precursor cells expressed developmentally down regulated 2) has been shown 
to increase SGK-1 ubiquitylation and degradation but only when the N-terminus of SGK-
1 is present [188].  Further analysis of the role of the N-terminus of SGK-1 in 
ubiquitinylation by NEDD4-2 has shown that a six amino acid hydrophopic motif 
(GMVAIL) is required for its ubiquitinylation [189].  In addition, it was shown that six 
lysine residues within the amino terminus that srrround the GMVAIL motif are also 
needed for ubiquitin modification [187, 189].  Deletion of the the GMVAIL residues was 
shown to prevent rapid SGK-1 degredation and disrupted its localization to the 
endoplasmic reticulum, where mutation of all 6 lysine residues also led to decreased 
ubiquitinylation and protein stabilization but did not disrupt SGK-1’s endoplasmic 
reticulum localization indicating that SGK-1 is ubiquitinylated in the ER [189].  Taken 
together, these results suggest that the activity of SGK-1 is regulated through its 
consititutive degredation which requires a unique N-terminal hydrophobic motif 
(GMVAIL). 
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5.1.3 The Role of SGK-1 in aldosterone-dependent Na+ reabsorption.   
 SGK-1’s involvement in aldosterone dependent Na+ reabsorption is the most 
studied function of the kinase with respect to epithelial transport.  The last point of 
control of renal Na+ excretion is the aldosterone-sensitive distal nephron (ASDN), [i.e. 
late distal convoluted tubule, connecting tubule, the cortical and medullary collecting 
ducts] [190].  In these segments of the kidney, Na+ transport is accomplished by Na+ 
entry through ENaC (epithelial sodium channel) in the apical membrane and Na+ exit by 
its transport  via the Na+K+-ATPase in the basolateral membrane.   
ENaC is composed of three subunits (α,β,γ) and each subunit contains a C-
terminal PY (PPXY) motif that is involved in protein/protein interactions with tryptophan 
rich WW domains [191, 192].  Studies have shown that the PY motifs are binding sites 
for the NEDD4-2 ubiquitin ligase family and specifically NEDD4-2 [192-199].  The 
mechanism of NEDD4-2 regulation of the channel requires the binding of the ENaC’s PY 
motif to NEDD4-2’s WW domain allowing for ubiquitylation of the channel resulting in 
its internalization and degradation.    
Alverez de la Rossa et al., [200] have shown that co-expression of ENaC with 
SGK-1 in Xenopus significantly increases the activity of the channel by increasing the 
number of channels present in the membrane as well as increasing the activity of 
channels already present in the membrane [190, 200-207].  The increase in channel 
number is likely due to interaction of SGK-1 with NEDD4-2 via interaction of SGK-1’s 
PY-motif with the WW-domain on NEDD4-2 followed by phosphorylation of NEDD4-2 
by SGK-1 (figure 5-2).   
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Figure 5-2: Regulation of ENaC by SGK-1 [173]. 
Aldosterone induces the expression of SGK-1 by binding to the mineralocorticoid receptor (MR) 
and translocating into the nucleus. SGK-1 becomes phosphorylated on Ser422 by an unknown 
kinase referred to tentatively as 3-phosphoinositide-dependent protein kinase (PDK)-2 or 
hydrophobic motif (H-motif) kinase; this latter kinase depends on the PI-3K pathway and is 
stimulated by insulin or IGF-1. Phosphorylated Ser422 then serves as a binding site for PDK-1 
via PIF-pocket, leading to the phosphorylation of Thr256 on the activation loop and activation of 
SGK-1. Alternatively, SGK-1 is also activated by WNK1 via an unknown mechanism. Once 
activated, SGK-1 phosphorylates Nedd4-2 on Ser444 and Ser338, which allows binding of 14-3-3 
on Ser444. This interferes with Nedd4-2/ENaC interaction, causing reduced ubiquitylation of and 
accumulation of epithelial Na+ channel (ENaC) at the plasma membrane. 
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This mechanism has been examined in Xenopus oocytes, where it was discovered 
that SGK-1 induces NEDD4-2 phosphorylation of Ser-444 and Ser-338 resulting in the 
creation of a binding site for the scaffold protein 14-3-3 [208].  Binding of NEDD4-2 to 
14-3-3 prohibits its association and ubiquininylation of ENaC, resulting in a decrease in 
ENaC endocytosis and an increase in the number of channels in the membrane [202, 208-
210].   
Another proposed method of SGK-1 regulation of ENaC is via direct interaction 
with the channel resulting in phosphorylation of the α-subunit, leading to a two to three 
fold increase in channel activity [211, 212].  Additional studies using Xenopus A6 cells, 
which endogenously express SGK-1 and ENaC, confirmed the previous findings as well 
as raising the possibility that the increase in ENaC activity is not only the result of 
activation of membrane resident channels, but also due to insertion of more channels into 
the membrane [213].  In addition to ENaC, SGK-1 has been shown to regulate an 
increasingly large number of transport proteins.  Multiple studies have been dedicated to 
the role of SGK-1 in regulation of such proteins such as ROMK and Na+-K+-2Cl- co-
transporter as well as mediation of the stimulation of NHE3 (Na+/H+ exchanger isoform 
3) [214-216].   
5.1.4 SGK-1 and CFTR. 
 
It has been well established that the gill operculum of the killifish, Fundulus 
heteroclitus, is stimulated to secrete chloride in response to increased salinity when the 
fish moves from fresh water to a saltwater environment [217-219], requiring the gills to 
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switch from NaCl absorption to NaCl secretion [220, 221].  Transepithelial Cl- secretion 
in the gills involves Cl- entering the cell from the basolateral membrane via NKCC1, 
which is dependent on the action of the sodium-potassium-ATPase generating a sodium 
gradient across the basolateral membrane.  The Cl- entering the cell is secreted via CFTR 
which generates an apical negative transepithelial voltage providing the driving force for 
paracellular sodium secretion [220]. Sufficient chloride export is facilitated by a 9-fold 
increase in CFTR mRNA levels in the first 24hrs following the move to a high salt 
environment, leading to an increase in CFTR expression in the apical membrane [222, 
223].  The increased expression of CFTR is preceded by a dramatic increase in the 
plasma levels of the steroid cortisol, a signal that activates SGK-1.  These observations 
suggest that SGK-1 may play a role in increased chloride secretion by activation of 
CFTR.  This was confirmed by studies in Xenopus oocytes in which SGK-1 was shown to 
stimulate CFTR while the kinase dead SGK-1 mutant (K127N) had no effect [224].  
Furthermore, studies by Sato et al., [225] have shown that in addition to stimulating 
chloride currents, SGK-1 also has the ability to increase the maximal stimulated current 
elicited by cAMP/PKA agonists, possibly by increasing the number of channels in the 
membrane. Moreover, they also report that SGK-1 stimulation may be mediated by 
protein/protein interactions involving the PDZ interacting motif [225].  
The effect of SGK-1 on CFTR currents is well documented [220, 221, 224-226], 
however the mechanism of its action is not very well understood.  The focus of this study 
was to elucidate the mechanism of SGK-1 action on CFTR which result in the observed 
increased chloride currents.  To this end, we used Xenopus oocytes as a heterologous 
expression system to examine the effects of SGK-1 stimulation on various CFTR 
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constructs.  Our studies show that co-expression of the constitutively active SGK-1 
(S442D) with WT-CFTR resulted in a significant increase in stimulated chloride current 
(ΔIm) but did not increase the change in membrane capacitance (ΔCm) following 
stimulation compared to WT-CFTR alone, suggesting that SGK-1 does not increase the  
trafficking response of CFTR upon stimulation.  To examine the effects of SGK-1 on 
CFTR surface expression we used we used a CFTR construct with an HA tag in the 
second extracellular loop (EXT-CFTR) provided by Dr. J. Riordan (UNC-CH).  When 
co-expressed with S422D-SGK, EXT-CFTR functioned similarly to WT-CFTR, 
stimulation resulted in an increase in ΔIm without an increase in ΔCm.  Using the EXT-
CFTR construct to examine cell surface fluorescence, we demonstrated that SGK-1 co-
expression increased cell surface expression following stimulation, similar to WT-CFTR.  
However, when cell surface expression was measured prior to stimulation, SGK-1 co-
expression resulted in a significant increase in the amount of CFTR resident in the plasma 
membrane.   
To examine the effect of the elimination of the kinase activity on ΔIm, ΔCm and 
cell surface expression, we co-expressed WT-CFTR or EXT-CFTR with the kinase dead 
SGK-1 mutant K127N.  As Stato et al, [225] reported, K127N co-expression with WT-
CFTR did not increase Im over that observed in its absence and it did not have an effect 
on the ΔCm upon stimulation.  Additionally, measurements of cell surface expression 
using EXT-CFTR, show that the removal of the kinase activity of SGK-1 eliminated the 
increase in the amount of channels in the membrane prior to cAMP/PKA stimulation 
indicating that the kinase activity of SGK-1 is critical for the increase in channel 
trafficking to the membrane prior to stimulation.   
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 To determine the structural element(s) of CFTR that mediates the effect of SGK-
1 on CFTR activity, we examined the effects of co-expression of S422D with the R-
domainless construct ΔR-N/C.  The elimination of the R-domain had no effect on the 
basal Im or the stimulated current when co-expressed with S422D, indicating that the 
presence of the R-domain is essential for SGK-1 regulation of CFTR activity.  Taken 
together our results suggest that SGK-1 regulates CFTR chloride currents by increasing 
the number of channels in the membrane prior to stimulation and this process requires the 
kinase activity of SGK-1 and the presence of the R-domain of CFTR. 
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5.2 MATERIALS AND METHODS. 
5.2.1 Preparation of Xenopus oocytes. 
The preparation and isolation of individual stage V or VI oocytes was performed 
as stated previously (section 2.2).  Briefly, ovaries were surgically removed from female 
Xenopus laevis frogs and placed in 1X MBS (table 2.1).  The ovaries were then cut into 
small sections and placed in a collagenase solution for 50 min to separate individual 
oocytes.  Following collagenase treatment the oocytes were washed three times in 
hypertonic solution followed by a 15 min incubation in the same solution with agitation 
every 5 min.  After the treatment in hypertonic solution the oocytes where then washed 
three times in 1X Ca2+ free ND-96 and placed in a 100mm pitri dish containing 1X 
MBS++ (table 2.1) at 18˚ C for a minimum of two hours prior to sorting.  Sorting of 
individual oocytes was performed using a dissection microscope with oocytes bathing in 
1X MBS++.  When a sufficient amount of individual stage V or VI oocytes were sorted 
they were incubated overnight at 18°C in 1X MBS++.  
After incubation, individual oocytes were injected with cRNA as detailed 
previously (Section 2.3).  cDNA constructs of SGK-1  used to generate cRNA were 
kindly provided by Dr. Bruce Stanton (Dartmouth, NH).  cRNA was produced using the 
mMessage machine RNA production kit from Ambion (Huston, TX) according to 
manufacturer’s suggestions (see section 2.4) and then injected into oocytes for 
expression.  To accomplish this, we followed a modification of the protocols described in 
Cunningham, et al., [145], and Gurdon, et al., [146].  In our protocol, we injected cRNA 
constructs into oocytes in 50nl volumes using a micro-injection apparatus (World 
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Precision Instruments, Sarasota, FL).  To obtain the desired amount of cRNA to be 
injected, we diluted the stock cRNA using DEPC-treated H20 (Ambion, Houston TX).  
When multiple cRNAs were to be injected, they were co-injected into the oocyte in the 
same 50nl volume.  Following injection of cRNA the oocytes were placed in one well of 
a six well plate depending on which cRNA(s) were injected and allowed to incubate for 
1-3 days at 18˚ C to allow for maximal expression.    
 
5.2.2 Electrophysiology. 
In this series of experiments, we used two electrode voltage clamp to measure 
chloride currents from Xenopus oocytes expressing various cRNA transcripts.  The theory 
behind the technique was the same as previously described (section 2.7).  Briefly, oocytes 
were impaled with two 3M KCl-filled electrodes which were connected to a GeneClamp 
500B amplifier (Axon Instruments, CA) via Ag-AgCl pellet electrodes and referenced to 
the bath by two Ag-AgCl pellet bath electrodes.  The voltage clamp was controlled by an 
AXOLAB 1100 analog-to-digital/digital-to-analog interface board (Axon Instruments, 
CA) using a modification of the pClamp5.0 (Axon Instruments, CA) software which was 
generated by Takahashi & Qi et al., [136, 149].  Using the method detailed in section 2.7, 
we were able to record CFTR-dependent membrane currents (Im) and membrane 
capacitance (Cm) from Xenopus oocytes injected with various cRNA’s. 
To generate the current/voltage plots the voltage clamp was controlled by a 
GeneClamp-500B amplifier (Axon Instruments, CA) in conjunction with an AXOLAB 
Digidata 1200 analog-to-digital/digital-to-analog interface board (Axon Instruments, CA) 
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using pClamp 8.0 software (Axon Instruments, CA).  Once oocytes were impaled the 
holding potential was set to -30 mV. The pulse protocol in these experiments was a series 
of step voltages starting at -100 mV and moving to +100 mV in 20 mV increments 
following stimulation with 10μM isoproterenol.  Measurements were taken at a point 
prior to stimulation of oocytes followed by a measurement every 5 min until maximal 
stimulation was observed.  The I/V curves shown are from individual oocytes where 
measurements were taken prior to stimulation and at maximal stimulation. 
5.2.3 Luminometry 
The protocol for luminometry used in these experiments is described in detail in 
section 2.6.  Briefly, labeling of CFTR at the cell surface utilized an externally epitope 
tagged CFTR construct (EXT-CFTR, [148]), kindly provided by Dr. John Riordan (UNC-
CH).  For oocyte studies, EXT-CFTR (10ng) or WT CFTR (1ng) cRNA was injected 
together with β2-AR and incubated in MBS++ for 3 days at 18˚C.  Oocytes were 
stimulated with 10 μM isoproterenol (Sigma, MO) as in the electrophysiological studies.  
Non-stimulated oocytes were treated identically except for agonist additions.  For 
chemiluminescence measurements, cell surface EXT-CFTR was labeled by sequential 
incubations in primary monoclonal HA antibody (1:1,000, 90 min) [Covance, New York, 
NY], secondary biotin-conjugated goat anti-mouse IgG (1:200, 90 min) [Invitrogen, 
Eugene, OR], and streptavidin conjugated to HRP (1:500; 90 min) [Zymed, San 
Francisco, CA].  All steps were performed at 4°C to block CFTR trafficking.  The cells 
were then washed extensively and HRP-labeled proteins were detected using SuperSignal 
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West Femto chemiluminescent substrate (Pierce), and read in a TD20/20 luminometer 
(Turner, Sunnyvale, CA). 
   
5.2.4 Statistics and Calculations. 
All data are presented as means ± S.E., where N- indicates the number of 
individual Xenopus laevis frogs from which oocytes were extracted and n- is the number 
of individual oocytes measured.  Statistical analysis was performed using a Student’s 
unpaired t test. A value of p ≤ 0.05 is considered statistically significant and indicated by 
a (*). All 2EVC recordings were performed on oocytes harvested from at least 3 different 
Xenopus frogs to ensure the reproducibility of our results. Half-life determination was 
accomplished by calculating the τ values using the exponential decay, single, two-
parameter regression function of SigmaPlot 2001 (SPSS, Chicago, IL).  
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5.3 RESULTS 
5.3.1 SGK-1 increases stimulated chloride currents but does not increase Cm. 
Previous work by Sato et al., [225] demonstrated that co-expression of WT-CFTR 
with the constitutively active form of SGK-1 (S422D) resulted in an increase in 
stimulated chloride currents from Xenopus oocytes. The results shown in figure 5-3 A&B 
confirm their findings, showing that stimulation of oocytes expressing WT-CFTR + 
S422D resulted in approximately a 1.7 fold increase in isoproterenol induced Im (WT-
CFTR 3.9±0.8 μA vs. WT-CFTR/S442D 6.8±0.8μA) which is similar to the increase 
reported previously [225].  Both WT-CFTR & WT-CFTR + S422D) showed a 
stimulation dependent increase in Cm (figure 5-3C) but co-expression of S422D did not 
result in a significant increase in the capacitance change (ΔCm) compared to oocytes 
expressing only WT-CFTR (WT-CFTR ΔCm=80±26 nF vs. WT-CFTR + S422D 
ΔCm=113±22 nF).   
As described in sections 3&4, cAMP/PKA stimulation mobilizes CFTR 
containing vesicles from an intracellular pool to fuse with the plasma membrane which is 
reflected as an increase in Cm.  Figure 5-3 shows that co-expression of SGK-1 with WT-
CFTR increases ΔIm but has no effect on ΔCm which indicates that the effect of SGK-1 
on CFTR Im is not the result of stimulation induced trafficking of the channel.  These 
data indicate that SGK-1 does not act like PKA.  Rather, SKG-1 either increases CFTR 
Po or results in trafficking of the channel to the plasma membrane prior to stimulation by 
PKA.    
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Figure 5-3: SGK-1 expression increases CFTR chloride current. 
Xenopus oocytes injected with 1ng WT-CFTR, 5ng S422D and 1ng β2-adrenogeric 
receptor cRNA.  A; current/voltage relationship from individual oocytes expressing WT-
CFTR or WT-CFTR + S422D before and after the addition of 10μM isoproterenol. 
Stimulated recording data was taken at maximal stimulation which was achieved by 
bathing oocyte in 10μM isoproterenol for 12 min. B & C show summary data of Im and 
Cm from 2EVC recordings.  Current data shown was recorded from a hyperpolarizing 
pulse to -60 mV from a holding potential of -30mV. [WT-CFTR: N=4; n=19; WT-CFTR 
+ s442D: N=4; n=14].   
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5.3.2 SGK-1 increases surface expression of CFTR prior to stimulation. 
To determine whether SGK1 increased CFTR cell surface expression, we used a 
CFTR construct with an HA tag in the second extracellular loop (EXT-CFTR) provided 
by Dr. J. Riordan (UNC-CH) which  behaves functionally like WT-CFTR [148] 
[described in section 2.6].  Figure 5-4 shows the results of two-electrode voltage clamp 
recordings of oocytes injected with EXT-CFTR cRNA alone or together with cRNA 
encoding constitutively active SGK1 (S422D). SGK1 co-expression elicited a 2.5-fold 
increase in cAMP/PKA-stimulated membrane current (ΔIm = 6.35±0.4 μA) relative to 
EXT-CFTR alone (ΔIm=2.55±0.9μA), without markedly increasing basal currents (figure 
5-4B). These results are similar to those for WT-CFTR with and without S422D reported 
by Sato et al., [225], indicating that EXT-CFTR behaves similarly.  cAMP/PKA evoked 
changes in membrane capacitance (Fig. 5-4C) reflect stimulation-induced CFTR 
trafficking to the plasma membrane, which was not acutely enhanced by SGK1, similar 
to WT-CFTR co-expression with S422D.  Taken together, the data in figure 5-4 indicate 
that S422D effects EXT-CFTR similarly to WT-CFTR.   
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Figure 5-4: SGK-1 effects extope-CFTR similarly to WT-CFTR. 
A:  I/V plots displaying mean current values at each voltage for oocytes expressing EXT-
CFTR or EXT-CFTR + S422D under basal and stimulated conditions (see legend).  
Stimulated data was taken at maximal stimulation which was achieved by bathing oocyte 
in 10μM isoproterenol for 10 min.  B&C:  summary data from Xenopus oocytes 
expressing EXT-CFTR taken at -60mV. A) membrane currents (Im) in oocytes co-
expressing (cRNA): EXT-CFTR (10ng) + β2-adrenergic receptor (1ng) ± S422D SGK1 
(5ng) [N=4; n=19,20]. cAMP stimulation by 10µM isoproterenol. B) Corresponding 
membrane capacitance (Cm) values.   
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Next, we evaluated the effect of SGK1 on cell surface EXT-CFTR density using 
enzyme linked immuno-labeling and luminometry [154, 155]. Oocytes were incubated 
sequentially with primary α-HA, biotin-conjugated α-mouse secondary and streptavidin-
HRP conjugated tertiary antibodies. Co-injection of SGK1 produced a 3.5-fold increase 
in cell surface CFTR luminescence prior to stimulation (figure 5-5A) compared to EXT-
CFTR alone.  The addition of 10μM isoproterenol resulted in an increase in cell surface 
expression of both EXT-CFTR and EXT-CFTR + S422D (figure 5-5B).  Previous studies 
have shown that cAMP stimulation mobilizes CFTR to the plasma membrane from 
intracellular compartments [136, 137, 149]. These findings suggest that SGK-1 can 
increase the cell surface expression of CFTR in the absence of cAMP stimulation, which 
augments the subsequent Im response to isoproterenol. 
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 Figure 5-5: SGK-1 increases CFTR cell surface expression. 
Luminescence detection of HA-tagged CFTR at the cell surface using an HRP ELISA 
sandwich method described in section 2.6. Data are background subtracted and 
normalized to control.  Panel A shows results of measurements taken of oocytes without 
stimulation [N=3; n=15].  Panel B shows measurements obtained following stimulation 
(10μM isoproterenol) for 10 min [N=3; n=15]. (*) indicates significant difference 
compared to EXT-CFTR under basal conditions.   
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5.3.3 Removal of SGK-1 kinase activity eliminated increases in Im and cell surface 
expression of CFTR 
To determine if the increases in chloride current and cell surface expression were 
dependent on the kinase activity of SGK-1 we co-injected WT-CFTR with the kinase 
dead mutant of SGK-1 (K127N).  Figure 5-6-A&B shows the results of 2EVC recordings 
of oocytes expressing WT-CFTR alone or WT-CFTR + K127N.  In panel (A), recordings 
of Im clearly show that the previously observed increase in chloride current with S422D 
co-expression were eliminated when the kinase dead SGK-1 mutant (K127N) were co-
injected.  Corresponding measurements of Cm show that K127N did not alter the acute 
increase in membrane capacitance following stimulation, which suggests that the increase 
in stimulated CFTR chloride currents observed with S422D are dependent on the kinase 
activity of SGK-1.   
 Since the kinase dead SGK-1 mutant eliminated the increase in stimulated Im, we 
next sought to examine its effect on cell surface expression. In the following experiments, 
we measured cell surface luminescence on Xenopus oocytes expressing EXT-CFTR or 
EXT-CFTR + K127N.  Figure 5-6-C shows that the increase in cell surface CFTR 
expression under basal conditions is dependent on the kinase activity of SGK-1.  
Following stimulation, oocytes expressing K127N showed an increase in cell surface 
luminescence similar to EXT-CFTR alone.  Taken together, theses data demonstrate that 
the elimination of the kinase activity of SGK-1 eliminates its ability to increase the ΔIm 
following stimulation by preventing the increase in number of channels in the membrane 
prior to stimulation. 
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Figure 5-6 Co-expression of WT-CFTR with K127N eliminates increases in Im and cell surface 
expression. 
Oocytes injected with 1 ng β2-adrenogeric cRNA and 1 ng CFTR or 10ng EXT-CFTR cRNA 
alone or with 5 ng of cRNA for K127N-SGK-1. On day 3 post injection short circuit currents or 
luminescence were measured as described in sections 2.6 and 2.7 respectively. A: Short circuit 
currents at -60 mV are presented as mean currents ± SEM.  B:  Measurements of membrane 
capacitance under basal and stimulated conditions.  C&D: Luminescence detection of HA-tagged 
CFTR at the cell surface. All data are background subtracted and normalized to control (basal 
EXT-CFTR) .  C: shows results of measurements taken of oocytes without stimulation [n=15; 
N=3].  D: measurements obtained following stimulation (10μM isoproterenol) for 10 min [n=15 
N=3]. (*) indicates significant difference compared to EXT-CFTR under basal conditions. 
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5.3.4 Removal of the R-Domain of CFTR eliminates effects of SGK-1 
The CFTR R domain contains 5 potential SGK1 phosphorylation sites as assessed 
by Scansite software [227] (aa 700, 768, 788, 795, 813).  Since the R-domain is the major 
site of phosphorylation-dependent CFTR stimulation, we sought to determine if removal 
of the R-domain would eliminate the influence of SGK1 on Im.  Therefore, we co-
expressed SGK1 with split CFTR cRNAs lacking the R domain (aa 1-634 + 835-1480; 
termed ΔR-N/C).  As shown in Fig. 5-7-A, ΔR-N/C does not respond to cAMP/PKA 
stimulation, but generates large spontaneous basal currents, similar to those observed 
during cAMP/PKA stimulation of WT-CFTR.  Furthermore, SGK1 does not augment 
ΔR-N/C Im (Fig. 5-7-B).  These findings suggest that the R-domain is required for 
increases in CFTR current during SGK1 co-expression. 
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Figure 5-7: Removal of R-domain eliminates the effect of SGK-1 
Im in oocytes expressing ΔR-N (0.5ng) + ΔR-C (0.5ng) + β2-adrenergic receptor 
(1ng) [n=16]; B) same, with SGK1 (5ng) co-expression [n=20]. Stimulation as in Fig. 
5-1.  
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Figure 5-8: S442D-SGK has no effect of functional half life of CFTR. 
CFTR current decay in oocytes bathed in 10μM BFA, expressing CFTR (1ng) + β2-adrenergic receptor 
(1ng) without (●) or with SGK1 (5ng) (∆); Periodic stimulation as described in Fig 3-3 [n=15 N=3]. 
[t½WT-CFTR= 16.1±4.3hrs; t½WT-CFTR+S422D-SGK=10.7±2.4hrs] 
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5.4 DISCUSSION: 
In summary, SGK1 stimulates CFTR Im by increasing CFTR expression at the cell 
surface, as determined by labeling of epitope-tagged CFTR. This increase in CFTR 
density was not due to a decrease in CFTR endocytosis, as indicated by functional studies 
of plasma membrane CFTR turnover (figure 5-8). Finally, SGK1 stimulation of CFTR 
current requires its kinase activity and the presence of the R domain. As shown by other 
work, the non-phosphorylated R domain is responsible for CFTR retention within the cell 
in the absence cAMP/PKA stimulation [228].  Therefore, the present findings are 
consistent with two possible mechanisms of SGK1-mediated redistribution of CFTR to 
the cell surface:  
5.4.1 SGK1 phosphorylates the R domain to promote CFTR trafficking to the 
plasma membrane without markedly increasing its gating,  
It is well established that SGK-1 is involved in the regulation of several ion 
transporters [193, 202, 216, 229-232], and earlier studies have shown that SGK-1 
increases CFTR chloride currents [224, 225]. However, the mechanism by which SGK-1 
increases CFTR chloride currents is not known.  Our data show that the effect of SGK-1 
on Im of WT-CFTR expressing ooctyes is dependent on the presence of the R-domain of 
CFTR.  Analysis of the amino acid sequence of the R-domain revealed the presence of 
five potential SGK-1 phosphorylation sites which when removed (along with the entire 
R-domain) in the presence of S442D eliminated theincrease in chloride current (figure 5-
7).  Additional work in our lab has demonstrated that phosphorylation of the R-domain of 
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CFTR results in an increase in the number of channels resident in the membrane [228].  
Our findings with the R-domainless construct (ΔR-N/C) suggest that SGK-1 may be 
working in a similar manner in that phosphorylation of the R-domain by SGK-1 induces 
CFTR trafficking to the plasma membrane.   Examination of the proposed SGK-1 
phosphorylation sites on the R-domain reveals that three of its phosphorylation sites ( 
S768, S795, S813) have been shown to be readily phosphorylated by PKA [113]. 
Since S442D is a constitutively active kinase, it is likely able to increase the basal 
phosphorylation state of CFTR, allowing CFTR channels to enter the plasma membrane 
resulting in an increase in the number of channels in the plasma membrane independent 
of PKA phosphorylation.  Figure 6.4A shows that the presence of S422D resulted in a 3.5 
fold increase in CFTR cell surface expression without cAMP/PKA stimulation.  
Additionally, when the kinase activity of SGK-1 was mutated, the increase surface 
expression of CFTR was eliminated.    Taken together, our findings suggest that the 
mechanism of SGK-1 regulation of CFTR chloride currents involves phosphorylation of 
the R-domain of the channel prior to stimulation allowing the channel to enter the plasma 
membrane increasing the amount of channels in the membrane.  
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5.4.2 SGK1 phosphorylation of another protein promotes CFTR progression to 
the cell surface.  
Another possible mechanism for SGK-1 regulation of CFTR comes from the 
work of Martel et al., [233].  In this study, they suggest that aldosterone-induced SGK-1 
regulates the activity of myosin Vc by phosphorylation of its tail region, resulting in 
ENaC’s increased association with trafficking proteins, leading to an increase in the 
amount of ENaC in the plasma membrane [233].   
This hypothesis was supported by their observation that SGK-1 phosphorylates 
myosin Vc tail at Ser-1539 in HEK-293 and M1 cells [233].  The tail region of myosin V 
family members has been shown to be responsible for binding cargo and regulation of its 
activity [234-243].  Additionally, ser-1539 is conserved across species and myosin V 
family members [233], and is part of a putative consensus sequence for other proteins 
(ex. PKA, PKC and Clk2), which when phosphorylated by calmodulin-dependent protein 
kinase II, regulated myosin V’s ability to interact with cargo [233, 244].  Taken together, 
these observations suggest that phosphorylation at this site on myosin V is the basis for a 
common mechanism of regulation of vesicular or organelle transport [233]. 
A link to this mechanism for CFTR, comes from work of Urban et al., [245],  
where they demonstrated a myosin V family member (myosin Vb) interacts with Rab11a 
to regulate recycling of CFTR and ΔF508-CFTR in polarized human airway epithelial 
cells [245].  Immunoprecipitation and western blot analysis on Calu-3 cells showed that 
endogenous CFTR interacted with myosin Vb and Rab11a [245].  Additionally, si-RNA 
knockdown of myosin Vb in CFBE41o- cells resulted in a decrease of CFTR in the 
membrane and inhibited forskolin induced short circuit currents [245]. 
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The above observations, in conjunction with our findings that SGK-1 co-
expression with WT-CFTR increases its trafficking to the plasma membrane prior to 
stimulation, support a possible mechanism where SGK-1 phosphorylates the C-terminal 
tail (ser-1539) of myosin Vb resulting in its increased association with CFTR/Rab11a, 
facilitating its transport to the plasma membrane. 
 
5.4.3 Future Directions: 
Future experiments will focus of further elucidation of the mechanism of SGK-1 
regulation of CFTR trafficking.  Our first experiment will be to mutate the 5 proposed SGK-1 
phosphorylation sites within the R-domain (S700, S768, S788, S795, S813) to alanine and 
examine the effects SGK-1 co-expression on Im and Cm as well as cell surface expression.  
Individual mutations will be studied as well as the effects of progressive ser/ala mutations until 
all 5 residues have been changed to alanine.  Additionally, we propose to examine the effects of 
SGK-1 co-expression with the R-domain deletion ΔNEG2.  As described in section(s) 3 &4, the 
NEG2 region of CFTR is essential for the channels regulated trafficking following cAMP/PKA 
stimulation.  In Lewarchik et al., [228], we proposed that when CFTR is unphosphorylated, the 
NEG2 region may interact with proteins that regulate trafficking, such as a SNARE protein, 
preventing its forward trafficking to the plasma membrane.  Since forward trafficking is 
stimulated by phosphorylation, it is possible that SGK-1 is regulating CFTR trafficking by 
phosphorylating the channel, preventing its interaction with trafficking proteins (ex. S1A) 
allowing for its delivery to the plasma membrane independent of cAMP/PKA stimulation. 
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To determine if myosin V is involved in the mechanism of SGK-1 regulation of CFTR 
trafficking, we will examine the effects of co-expression of the myosinVb-tail region we will 
perform a series of co-injection experiments in Xenopus oocytes to measure changes in Cm and 
measure cell surface expression using methods described in sections 2.6 & 2.7.  In these 
experiments we will co-express WT-CFTR with S422D with and without myosin Vb-tail.  This 
construct contains the SGK-1 consensus phosphorylation site and is able to interact with cargo.  
However, the myosin Vb-tail is not able to interact with the actin cytoskeleton which prevents 
forward trafficking of bound cargo [245].  Thus if SGK-1 regulates CFTR trafficking, via a 
myosin Vb dependent mechanism, co-expression of only the tail region should eliminate the 
effect of SGK-1 on CFTR stimulated Im as well as non-stimulated cell surface expression.   
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